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ABSTRACT
The ETS family transcription factor PU.1/Spi-1 is a master regulator of the self-renewal of
hematopoietic stem cells and their differentiation along both major lymphoid and myeloid
branches. PU.1 activity is determined in a dosage-dependent manner as a function of both its
expression and real-time regulation at the DNA level. While control of PU.1 expression is well
established, the molecular mechanisms of its real-time regulation remain elusive. Our work is
focused on discovering a complete regulatory mechanism that governs the molecular interactions
of PU.1. Structurally, PU.1 exhibits a classic transcription factor architecture in which intrinsically

disordered regions (IDR), consisting of 66% of its primary structure, are tethered to a wellstructured DNA binding domain. The transcriptionally active form of PU.1 is a monomer that
binds target DNA sites as a 1:1 complex. Our investigations show that IDRs of PU.1 reciprocally
control two separate inactive dimeric forms, with and without DNA. At high concentrations, PU.1
forms a non-canonical 2:1 complex at a single DNA specific site. In the absence of DNA, PU.1
also forms a dimer, but it is incompatible with DNA binding. The DNA-free PU.1 dimer is further
promoted by phosphomimetic mutants of IDR residues that are phosphorylated in B-lymphocytic
activation. These results lead us to postulate a model of real-time PU.1 regulation, unknown in the
ETS family, where independent dimeric forms antagonize each other to control the dosage of
active PU.1 monomer at its target DNA sites. To demonstrate the biological relevance of our
model, cellular assays probing PU.1-specific reporters and native target genes show that PU.1
transactivation exhibits a distinct dose response consistent with negative feedback. In summary,
we have established the first model for the general real-time regulation of PU.1 at the DNA/protein
level, without the need for recruiting specific binding partners. These novel interactions present
potential therapeutic targets for correcting de-regulated PU.1 dosage in hematologic disorders,
including leukemia, lymphoma, and myeloma.
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1
1
1.1

INTRODUCTION

Eukaryotic gene transcription
The blueprint of life is the DNA genetic code which contains the instructions for a cell to

sustain itself. Eukaryotic gene transcription is much more complicated than prokaryotic gene
transcription as the first one is carried out in the nucleus of the cell and translated into the
cytoplasm. This spatial separation allows eukaryotic gene expression to be regulated differently,
contributing to the vast eukaryotic forms and function (1). An additional level of complexity of
eukaryotic gene expression comes from the different promoter elements such as the TATA box,
CAAT box, initiation elements, and the downstream promoter elements (2), which can be
recognized other proteins than RNA polymerase II (1). Eukaryotes have three types of RNA
polymerases I, II, and III, while the prokaryotic expression only has one (3).
1.2

The central dogma of molecular biology
The central dogma of molecular biology shown in [Figure 1.1] demonstrates the whole

process from gene sequence to protein product. The concept was introduced by Francis Crick in
1957 and restated in 1970 in a Nature review (4).
There are three significant steps involved in molecular biology's central dogma: DNA
replication, transcription, and translation. DNA replication occurs when the genetic material of the
mother cell is passed down to its daughter cells. This replication process is highly regulated as it
is one of the most crucial steps of the survival of the cell, and (5) is controlled by a complex
regulatory machine involving numerous enzymes and proteins called the replisome (6). The
process requires a helicase to unwind the double-stranded DNA and a single-stranded protein
(SSP) that will inhibit it from reassembling. RNA primase will then create an RNA primertemplate for each strand, giving DNA polymerase III the green light to read the existing 3’ to 5’
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template and add new nucleotides from the 5’ to 3’of the new daughter strand. DNA polymerase I
will then remove the RNA primers leaving DNA ligase to join the two fragments by
phosphodiester bonds, creating an exact copy of the chromosomal DNA (5).
Transcription is making a messenger RNA (mRNA) that encodes the synthesis of the
desired protein from DNA in the nucleus of the cell. Transcription in eukaryotic systems has three
main stages: initiation, elongation, and termination. The initiation step begins with the assembly
of the pre-initiation complex (PIC), which is composed of several general transcription factors
(GTFs) and mRNA polymerase II (Pol II) [Figure 1.2] (7). The second step of transcription is
elongation which is a repetitive bond formation at each base pair in the DNA-track system (8). The
last step is termination, where the RNA polymerase II will fall off, causing a complete dissociation
of the mRNA produced from the DNA-RNA hybrid (9). Although all three transcription stages are
crucial for regulation, initiation is directly affected by proteins (called transcription factors) that
bind to a specific DNA binding site and modulate RNA polymerase II activity (10).
Eukaryotic transcription initiation includes many vital components such as gene-specific
transcription factors (activators/repressors), co-factors such as histone modifiers, chromatin
remodelers, general transcription factors, and the assembly of PIC (11) [Figure 1.2]. Transcription
initiation starts when a gene-specific transcription factor (TF) binds to an enhancer region of DNA,
allowing for a TBP (TATA-binding protein) binding to the TATA region (promoter region) and
induces a ~90o bend on the DNA (12,13). Next, general transcription factors TFIIA and TFIIB are
recruited following by Pol II and TFII, with the last one stabilizing DNA along with the branched
polymerase II (14). Finally, TFIIH and TFIIE are recruited to complete the eukaryotic PIC (15).
The PIC assembly and the TF at the enhancer region are then stabilized in place by a mediator
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complex through protein-protein interactions, and (16) once everything is in place, Pol II unwinds
four DNA turns with help from TFIIH and is ready to start transcription (17).
The last step of translation follows the conversion of mRNA into a protein by the ribosome
in the cell cytoplasm. Just like transcription, translation has three stages: initiation, elongation, and
termination. The first step begins when the ribosome assembles around mRNA at the AUG codon
(start codon) containing a Methionine-transfer RNA (met-tRNA) and reads mRNA from the 5’ to
3’ (18). The elongation step then takes over, which decodes codons and forms peptide bonds. The
whole elongation process has four sub-steps to sequentially add amino acids to the nearest peptide's
carboxy-terminal end and, therefore, complete the formation of a polypeptide (19). The
termination step is signaled by the presence of a STOP codon such as UGA, resulting from the
release of the polypeptide chain (20). The newly formed polypeptide chain undergoes posttranslational modification to become a fully functional protein that will go on to carry out its
function.
1.3

Eukaryotic transcription factors
1.3.1

Classification of transcription factors

Roughly 10% of the eukaryotic genome encodes for the expression of transcription factors
(21-23). Historically, the term transcription factor (TF) was given to any protein that contributed
to transcription or gene expression. As more data has emerged, the term can be more specific to
only proteins capable of 1) binding sequence-specific DNA and 2) regulating transcription (24,25).
In humans, roughly 300 TFs belong to the necessary transcriptional machinery, while
approximately 3000 TFs are sequence-specific DNA binding proteins (25). Some specific binding
TFs are found virtually in all organisms and cells because they are responsible for transcribing
“housekeeping” genes (11). In contrast, others serve as an activator or repressor of particular genes
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(26). In some cases, the same TF acts as both activator and repressor, such as ETS family
transcription factor ETV6 (27). TFs regulate genes by binding cis-acting enhancers (a segment of
DNA ~100 bps) and recruit co-activators/repressors and, in some cases, RNA polymerase II to
target genes (28). In embryonic stem cells, gene expression is surprisingly controlled by a small
number of transcription factors referred to as master transcription factors (28) or pioneering factors
due to their ability to overcome chromatin restrictions (29). PU.1 is considered a master
transcription factor due to its involvement in the regulation of both lymphoid and myeloid
progenitor cells in mice (30,31), B cells (32), as well as human monocytes and macrophages (33).
Transcriptional misregulation is responsible for many diseases and cancers (25), often due
to mutations in the DNA binding domain (DBD) of the transcription factors such as HOXD13,
which leads to limb malformation. Other times these diseases manifest with a strong immune
dependent component with B cell and T cell-specific genetic signals (34). The link between
transcription regulation and human diseases is clear. Therefore, it is important to stress the efforts
of understanding transcription factors real-time regulatory mechanisms.
1.3.2

Structure of transcription factors

The primary feature of transcription factors is their DNA binding domain (DBD), which
recognizes specific DNA sequences within their enhancer region of the genes they control. The
interaction of the DBD and the DNA occurs by the sidechains of the amino acids of the DBD
interacting with the nucleotide bases located in the double-helical DNA structure. Although minor
groove binders are reported, the interactions between the DBD and nucleotide bases allow
transcription factors to target DNA's major groove (35). The interactions between the DBD and
DNA is held in place by hydrogen bonding. Van der Waals contacts determine the transcription
factor's specificity and affinity to its DNA target site (36-39). Ionic interactions also play a role in

5
the stability of the positively charged residues of the DBD with the DNA phosphate backbone.
Additionally, the topology of the DNA (its curvature) influences the affinity a transcription factor
has to the target site (40), with some TF inducing DNA bending upon binding (41).
Transcription factors can be divided into families according to their DBD structural
characteristics [Figure 1.3]. These families include the zinc-finger (ZNF) motif (it is the most
common DBD motif of TFs with ~50% of known TFs (25)), the Homeodomains (HDs), Helixturn-helix (HTH), Helix-loop-helix (HLH), Basic protein-leucine-zipper (bZIP) and the winged
helix-turn-helix (wHTH). [Figure 1.3] shows an example of a transcription factor of each of the
most common motifs.
The second essential domain is the transactivation domain (TAD), which serves as a
contact for transcription co-activators (42). It is suggested the TAD facilitates interactions of the
recruitment of the transcription machinery during initiation. Furthermore, it has been observed that
TADs tend to be intrinsically disordered with a high number of acidic and hydrophobic residues,
giving it the name of “acidic blobs and negative noodles” (43). An additional optional domain is
a signal-sensing domain such as the PEST domain of ETS family transcription factor PU.1, which
serves as a prosomal recruiting signal for metabolic turnover (44). The PEST domain stands for
the abundance of the proline (P), glutamic acid (E), serine (S), and threonine (T), and similarly to
the TAD domain, it is highly acidic and intrinsically disordered. Eukaryotic transcription factors
are composed of a higher percentage of intrinsically disordered regions than prokaryotic
transcription factors (45). As a further breakdown, there are broadly two types of eukaryotic
transcription factors [Figure 1.4]. Type I only has the DBD as a well-folded domain tethered by
intrinsically disordered regions on both N-terminal and C-terminal. In contrast, Type II has other
well-structured domains serving many functions in addition to the DBD, which are connected by
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intrinsically disordered regions (45). This leads one to argue that eukaryotic transcription factors
have evolved to incorporate intrinsically disordered regions in their function. Therefore, it is
important to study these regions to understand their contribution to gene regulation fully.
1.3.3

Intrinsically disordered properties of transcription factor

A genome-wide analysis study showed that ~25% of eukaryotic proteins have intrinsically
disordered regions with more than 50 residues (46). For a while, prior biological significance was
only attributed to proteins with a well-defined tertiary structure (47). However, it was discovered
that intrinsically disordered proteins (IDP), even though lacking well-folded domains, have several
motifs that interact with RNA, DNA, or other proteins (48). The amount of IDRs these proteins
possess in larger than 200-300 residues (~80% of the protein) and are determined by the presence
of specific amino acids (P, E, S, Q, and K) (49). There are different time scale dynamics that
proteins undertake depending on the motion involved, such as partial folding (slower timescale)
or vibrational and loop motions (faster time scale) (50). One dynamic process that required changes
in torsion angles of the backbone polypeptide is responsible for conformational changes (51). Only
two rotations are allowed for a polypeptide backbone the N-Cα bond named ϕ and Cα-C bond
called ψ (52). These torsional dynamics are fundamental for any protein dynamics and can be
mapped by Ramachandran ϕ-ψ conformational space. Typical α-helix and β-sheet secondary
structure have angles that cluster around ~60 ψ/-60ϕ and ~ 120 ψ/-120 ϕ, respectively [Figure 1.7].
IDPs or proteins with IDRs dynamics arise from the Ramachandran dihedral angle fluctuation due
to their random-coil similarities and a lack of well-defined secondary structure. IDPs have been
shown to have high biological relevance as they are found in transcription factors, ribosomal
proteins, and ribonucleoproteins complexes (47) and are associated with different functions and
diseases (47,53,54). A challenging aspect of characterizing IDPs or proteins with IDRs are the
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same features that make them interesting in the first place: lack of structure. The techniques to
analyze these type of proteins are limited to a handful of examples including circular dichroism
(CD) and NMR (47).
CD spectroscopy is a technique that characterizes the protein by the secondary structure
(alpha helix, beta-sheets, and random coil) by monitoring in the far UV region (170-250nm) (55).
CD provides structural data of IDPs and IDRs. Alpha helical proteins have a distinct double
negative trough at 208nm and 222 nm and a peak at 190 nm. Beta sheets proteins also have distinct
trough patterns at 217 nm and a peak at 198 nm (47). While IDPs or proteins rich in IDRs have a
strong negative signal at 200 nm, very similar to the random coil, supporting the idea that IDPs
and IDRs lack a well-folded secondary structure (56-58).
NMR spectroscopy is another technique that provides excellent insight into the nature of
long IDRs (59). Typically, a triple-resonance (13C, 15N, and 1H nuclei) experiment is used to find
the neighboring residues' sequential connection. For globular proteins, these residues are dispersed
throughout due to their chemical environment. While, IDRs tend to cluster around 8.2 ± 0.2 ppm
in 15N-1H spectra, creating a spectral overlap and, therefore, difficult to distinguish residue signals
(60). This feature is very typical of IDRs and IDPs, reinforcing the idea that they are dynamic. 1H15

N Heteronuclear nuclear Overhauser effects (NOEs) is a method often used to identify the

dynamics of IDRs residues as they have low signal or entirely negative signals. In contrast,
residues in the structured domain have high positive values. NOE values come from the ratio of
the saturated spectrum's peak intensities to the unsaturated spectrum (61).
1.3.4

Regulation of transcription factors

Gene regulation is crucial in living organisms, as the misregulation of the initiation stage
of transcription often leads to a broad range of diseases (62). Gene expression is a complicated
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process involving the organization of numerous multi-level events of regulation. The primary
regulators of gene expression are transcription factors, which beg the question: what regulates
these regulators upon binding to their specific DNA sequence? The multi-level complexity of
understanding the interactions between TFs and DNA arises from the involvement of other
cofactors, cooperative binding of other transcription factors such as interferon regulatory factor
(IRF4) with PU.1 (63), as well as epigenetic modifications like DNA methylation, post-translation
modification, chromatin remodeling and histone modification (64). However, TFs can also utilize
its structure to regulate the DNA binding affinity by auto-inhibition. ETS-1 is an example of a TF
that undergoes a structural transition of unfolding helix HI-1 upon binding DNA (65). Additional
regulation arises from the surrounding environmental stress response that diverges the attention
from proliferation to stress protection such as DNA damage, stressed repressed genes, defense
against reactive oxygen species, and osmotic stress (66). Other times TFs will form a homodimeric complex to regulate their DNA binding activity. Tryptophan repressor protein (TR) is an
excellent example of a TF that utilizes dimerization and the environmental response to repress
genes when tryptophan concentration is high. TR does so by using hydration as part of its
mechanism where interfacial waters are fundamental for its thermodynamic stability and the active
complexation of TR dimer with its specific target DNA (67).
Nature has evolved eukaryotic transcription factors to have a diverse sense of real-time
regulatory mechanisms, as described above. However, considering that most of these transcription
factors are enriched within intrinsically disordered regions, it is interesting to explore their role in
self-regulation at the DNA level. Due to their disordered nature, these domains are often left
unstudied, leaving the full characterization only to the well-folded DBD. This presents an
incomplete representation of gene regulation and a gap in basic biophysical knowledge of each
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domain of the transcription factor's role. We have selected transcription factor PU.1, a member of
the ETS family, as an ideal model to study how hydration (response to osmotic pressure) and
intrinsically disordered regions modulate the real-time regulation at the DNA/protein level.
1.3.5

Hydration of proteins

Water is the most abundant molecule on Earth, covering ~70% of the surface. Water has
shaped the way life on Earth has evolved as hydration interactions highly influence protein
molecules. Protein hydration, its dynamics, and packing have affected the way proteins can fold
and bind (68); therefore, characterizing the hydration patterns of proteins will determine the
energetics, stability, and recognition.
It has been observed that ordered waters are present in crystallographic structures (69) and
that they are involved in many regulatory processes such as DNA recognition (70), substrate
specificity (71), and catalysis (72). From the first solved structure of a protein bound to DNA, it
was apparent what elements play a role in the interaction: electrostatic interactions, ion release,
conformation rearrangement, hydrogen bonding, hydrophobic effects, direct contacts between
protein and DNA, and water-mediated contacts (73-75). The role of water in both free and proteinbound DNA has exhaustively been studied by both experimental and computational techniques as
different mechanisms have been proposed based on interaction and recognition (76). Water is
abundantly present and affects the specificity of the protein/DNA complex (77). At the local
interface of the protein/DNA waters can act as an intermediate bridge between protein/DNA or
interact dynamically. The contribution of hydration is due to the difference between the bulk water
medium and the waters in the local interface of the protein/DNA complex (78). The restriction
endonuclease EcoRI is an excellent example of how critical hydration contribution is in DNA
specific binding as the number of waters present determines its ability to bind high affinity or
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nonspecific DNA (79). The hydration patterns of protein/DNA ensembles are critical in forming
the complex and the ability to bind specific high affinity DNA.
Advances in NMR and X-ray crystallography techniques have allowed for solving
numerous protein/DNA structures. Many crystallographic complexes have revealed that the minor
groove of DNA is the most hydrated (80), and simulation studies have supported these
crystallographic/NMR observations (81). However, a current restriction with crystallography and
NMR is flexibility and size, respectively (82). Flexible proteins are hard to crystalize, and therefore
identifying the proteins' hydration patterns in those specific areas remains a mystery. The obstacle
with NMR and larger proteins (>30 KDa) has to do with increases in spectral complexity and
sensitivity loss (83). Other techniques such as hydrodynamics (ex: analytical ultra-centrifugation
AUC, densimetry) and solution scattering (ex: small-angle X-ray scattering, (SAXS)) are often
used when crystallography and NMR are limited. These techniques have their advantages as they
can be used at very dilute solutions. There is no size limit; however they are low resolution, and
the interpretation of the data depends on the parameters involved (82).
Volumetric measurement techniques such as densimetry and hydrostatic pressure are often
used to provide insight into proteins' hydration. Interactions of charged residues of protein with
surrounding water molecules can change thermodynamics properties of bulk water and therefore
distinguish waters important for protein hydration (68).
1.3.5.1 Volumetric analysis to measure hydration in protein/DNA binding
The hydration patterns of a protein/DNA complex can be interpreted thermodynamically.
Micro-calorimetry gives accurate heat changes of macromolecules in an aqueous solution,
reflecting hydration at a specific condition (84). Thermodynamics profiles can be also be acquired
by placing the protein or complex (protein/DNA) under non-ideality conditions such as osmotic
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pressure and exclusion volumes (85). Pressure can be applied to bio-molecular systems [Equation
1] (protein-protein, protein-DNA) to study the complex conformational and supramolecular
structure without altering the bond angles and bond length.


P  D 
 PD
K
D

(1)

where P stands for protein and D for DNA. The experiments' pressure is typically ranging
from 1 bar to 10 kbar (86). The effects of pressure on chemical equilibrium can be described by
[Equation 2]
V
  ln K 
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Where K is the pressure-dependent- equilibrium constant, and ΔV is the associated reaction
volume. The volume change is measured by the partial molar volume of the products subtracting
the reactants (86,87). [Equation 3]
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Densimetry is a technique used to calculate the partial molar volume V o [Equation 4]
Vo 

M
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M is the solute's molecular weight, and ρo is the density of the buffer, ρ is the density
measured, and C is the concentration of the molar solute. The change in volume includes the
volume of complex formation as well as the hydration volume, and it can be expressed in three
additive parts [Equation 5]
V  VM  VT  VI

(5)

Where VM is the intrinsic volume of the solute and ΔVM is the change is solvent excluded
volume. ΔVT is the change in thermal volume (configurational dynamics). Finally, ΔV I is
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interaction volume, which changes hydration in binding (Δn h). For the hydration of a protein
binding to DNA this is the most critical parameter as it gives us insight into how many water
molecules are released: where the denominator (Vh-Vo) are taken to be -1.8 cm3/mol [Equation 6]
nh 

VI
V  Voo
o
h

(6)

Densimetry is a useful technique in determining the protein's density changes as it
undergoes different interactions (self-association or protein-DNA). However, densimetry is also
limited to high concentrations as sensitive as other techniques such as osmotic pressure.
Hydrostatic pressure is another technique used to study proteins under stressful conditions
posed by pressure. Hydrostatic pressure is a significant biological feature as it essential for many
extremophile organisms (88) that populate the ocean floor where the pressure is 1,100 atm (89,90).
Some bacterial species have also been found deep in the Earth’s crest, where the temperature is
102oC, and the pressure is 3,000 atm (91). These discoveries of organisms living in such a harsh
environment have led many to question how proteins, DNA, and RNA can alter their physical
chemistry to hydrostatic pressure (90). Hydrostatic pressure perturbs the volume of the system
without changing the internal energy (92). Hydrostatic pressure experiments are carried out by
applying excessive pressure to the system of about 10 kbar (9.87 atm) as the goal often is to
promote dissociation and disturbance of globular structure (92). Increasing hydrostatic pressure
disturbs the equilibrium between native, N, and unfolded, U, states of the protein [Equation 7].


U
N 


(7)

For a two-state equilibrium process, the pressure alteration is defined by the volume change upon
unfolding (90) [Equation 8].
  ln K 
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(8)
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One particular limitation of hydrostatic pressure is that you require prior knowledge of a
structure for better accuracy. Additionally, the instrumentation available to carry the
experiments is costly, and accurate measurements require a constant sample density throughout.
1.3.5.2 Osmotic pressure on protein/DNA binding
Osmotic pressure (93) experiments can be used to determine the number of water
molecules released upon binding as well as determine specific and nonspecific DNA binding
(94,95). For example, osmotic pressure studies of hydration changes have been useful in studying
binding substrate to hexokinase (96). As the substrate binds to hexokinase, its estimated
dependence affinity on osmotic pressure is visible from the osmotic work done to remove the
waters from the osmolyte-excluded cavity. Therefore, the volume of waters removed is calculated
by osmotic pressure and osmotic work (97). The osmolyte-excluded cavity refers to the volume of
the osmolytes that are excluded (97). Osmolytes are osmotic agents, such as urea, which denatures
proteins, crowders that exclude the volume of proteins or complexes (ex. Polyethylene glycol
PEG), and non-ionic co-solutes (ex: betaine) (98). Depending on the experiments, different
osmolytes for different outcomes are required.
Our focus is to determine ETS family protein hydration patterns, as is demonstrated in
chapter 2 between PU.1 and ETS-1. A widely neutral compatible non-ionic co-solute betaine (99)
was chosen to apply osmotic pressure on the protein/DNA complex. The data was analyzed by
interpreting the effects of betaine on the equilibrium constant under increasing osmotic pressure
(100). Assuming complete exclusion in binding from osmolyte (101) and the binding constant (log KD) as the equilibrium constant, we can use the equation in terms of osmolality where 55.5 is
molal of pure water while ΔVw is the hydration change between free and bound forms. Positive
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change in hydration is interpreted as water uptake and negative values of change in hydration as
net release [Equation 9].


1.3.6

Vw
 log K D

Osm
55.5ln10

(9)

It takes two to tango: dimerization in transcription factors

Dimerization is the process in which two proteins interact with one another. This
collaboration between two proteins could be heterotopic (proteins deriving from two different gene
families) or homotopic (proteins interacting with members of the same family) (102). Dimerization
is used as a regulatory mechanism depending on the partner choice and cellular system such as in
the cell cycle, immunity, development, metabolism, homeostasis, and programmed cell death
(102). For this reason, there is a high interest in understanding how these dimeric properties
evolved to develop therapeutic targets (103). Functional implications of dimerization allow
recognition of different DNA elements while the monomer-to-dimer transition can act as an
additional regulatory mechanism for transcription factors. Dimerization is also linked to protein
concentration, synergy, and allostery (104,105), as well as non-linear behavior such as oscillations
(106). A monomeric transcription factor could have different binding partners that interact with
one another in different ways (concentration, phosphorylation, or affinity). This promiscuous
behavior allows for extra layers of different gene regulations (102). Dimerization could occur in
solution as the two monomers associate and then bind to DNA, also referred to as dimer pathway,
or they bind to DNA as a monomer and then dimerize (monomer pathway) (107).
1.4

ETS family of transcription factors
The first ets oncogene was discovered in 1983 in avian erythroblast virus, E26, which also

gave it its name E-twenty-six-specific sequence (108). The ETS family is present throughout the
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whole animal kingdom with 28 ETS genes in humans classified into 12 subgroups based upon the
DNA-binding domain, also called the ETS domain (109) [Figure 1.4]. The ETS domain is
composed of ~85 residues that form a winged helix-turn-helix (wHTH) motif with three α-helices
and four β-sheets that recognize a core consensus GGAA/T [Figure 1.5]. Helix 3 is the recognition
helix as it makes contact with the major groove of DNA where the consensus GGAA/T is located.
Two arginines in Helix 3 make contact with two guanines in the ETS binding site. The binding
specificity of each member of the ETS family is determined by the flanking sequence of the DNA
as the core consensus is similar for all of them (110) as well as interaction with other nuclear
factors. (111).
Another conserved domain present in 11 out of 28 members is the pointed (PNT) domain.
The PNT domain has a well-structured sterile alpha motif (SAM) and is shown to be involved in
homo/hetero-dimerization as well as protein-protein interactions (111).
1.4.1

The biological role of ETS transcription factors and diseases

To date, there have been 700 ETS target genes identified (111). For a long time, it was
believed that the ETS members were either activators or repressors, while now we have a clearer
understanding that some of them can function as both depending on the type of promoter, making
a very diverse set of transcription factors. So far, 11 members are embryonic lethal, with the
majority demonstrating their role in hematopoiesis or combination with other lineage defects
(111). Hematopoietic regulators include PU.1, which is a key regulator for the differentiation of
both myeloid and lymphoid lineages (112), ETS-1(113) and Elf-4 (114), which are principal
regulators of T cells production, and Fli-1 (115) along with Etv-6 (116) and Etv-2 (117), which
display functions in angiogenesis. The ETS members involved in lethal non-hematopoietic defects
include Etv1 and Fev for defective neurogenesis (111), and Etv-5 for male fertility (118).
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Deregulated ets gene expression is linked to numerous diseases in humans, including
leukemia, thyroid, liver, prostate, colon, and breast carcinomas (119). The ETS transcription
factors have been found to regulate the expression of genes responsible for cancer cells that invade
the nearby tissues or move into the bloodstream to invade tissues all over the body called malignant
and metastatic processes (111). Examples of these processes include cell proliferation such as the
case for cdks and cyclins, invasion (ex: urokinase-type plasminogen activator; uPA), extravasation
(Integrins), motility (hepatocyte growth factor, HGF) as well as the maintenance of new blood
vessels that deliver oxygen to the tissues called angiogenesis (120). Correlation analysis further
demonstrates a connection between ets genes and the ETS transcription factors with the
progression of prostate cancer (121). SPDEF an ETS member has been shown by functional data
to negatively regulate uPA (122), and both have been found to be inversely correlated in colon
cancer (123).
1.4.2

Regulation of ETS transcription factors

ETS protein regulation depends on the complexes they form with different transcription
factors as it strengthens their activity interactions and specificity to the binding of DNA (111).
Many cofactors of ETS members have their DNA binding sites adjacent to the ETS DNA binding
site (124,125). Some of these cofactors include AP1 (fos/Jun) IRF4/8, PAX5, GATA1, to name a
few (111). ETS members Etv-1, Etv-4, Etv-5, and ERG have been shown to interact with AP1
transcription factors to activate MAPK in prostate cells in the absence of MAPK activators (126).
PU.1 interacts with IRF4 and IRF8 through the Ets/interferon consensus elements (EICE) to
regulate early B cell development (127). ETS-1, in collaboration with PAX5 allows for binding to
a non-consensus of ETS binding domain in early B-cell specific promoter (128). Another well-
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formed partnership is Fli1 and GATA-1, as they both work together to activate multiple
megakaryocytic genes such as gpIX, gpVI, and gpIb (129).
In addition to partner proteins, ETS factors are regulated by phosphorylation, acetylation,
ubiquitination, and sumoylation (111). Perhaps the most studied regulatory mechanism of ETS
proteins is phosphorylation, as it is crucial for protein-protein interaction, DNA binding, and
transcriptional activation. Many members (ETV-1, ETV-4, GABPA, ETS-1, ETS-2, SPIB, ELK1,
ELK-3, and ELK-4) can be phosphorylated by MAPKs to activate transcription (130). At the same
time, the ETV6 DNA binding affinity is weekend by MAPK phosphorylation as it is negatively
regulated (111). PU.1 utilizes phosphorylation of its S148 in the PEST region for protein-protein
interaction with IRF4 (131) as well as S41 in its TAD region is induced by AKT signal in a
phosphoinositide 3-kinase-dependent manner (132). Acetylation is another common form of
regulatory mechanism for ETS factors. For example, ETS-1 is acetylated as a response from the
TGFβ signal dissociating it from the CBP/p300 complex (133). Oppositely Etv1 has an increase
in DNA binding affinity when it is acetylated, activating its transcriptional genes. (134)
Additionally, ETS TFs get regulated by ubiquitination and proteasome degradation as well as
sumoylation as the latter shows a decrease in transcriptional activity for ETS-1, Etv-4, and Etv-5.
(111).
1.4.3

Dimerization of ETS proteins

Dimerization in the ETS family occurs differently for specific members. 11 members
possess a PNT domain, with ERG, SPDEF, and ELF subfamilies showing no reported activity.
Etv6 and its Drosophila homolog Yan dimerize through its PNT domain, which is a well-structured
domain. (109) The PNT domain allows Etv6 to self-associate (homodimer) (135) utilizing its
helical homo-polymers in a head-to-tail orientation (136-138). Homotypic interactions allow
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ETV6 to increase DNA binding affinity. Additionally, Etv6 forms heterodimeric complexes
through the PNT of other proteins such as NAD-dependent malic enzyme (Mae) to facilitate the
phosphorylation of Etv6 during MAP kinase Rolled (a Drosophila homolog of human MAPK3)
(109). These interactions (either homotopic or heterotopic) through the PNT domain are in
response to different signals.
Another way the ETS members dimerize is through their ETS domain. ETS-1 is a good
example of this as its DNA binding domain (ETS domain) has additional helices in the N-terminus
that act as an auto-inhibitory region. These helices (HI-1 and HI-2) will unfold as ETS-1 binds
cooperatively as a homotopic dimer to DNA in a palindromic head to head fashion offsetting autoinhibition (139). Experiments with a short form of ETS-1 lacking the auto-inhibitory regions
proved that the protein does not form a homotopic dimer meaning that the N-terminal elements
are crucial for the cooperativity mechanism of ETS-1 (140).
Another family member that utilizes the ETS domain to dimerize is GABPA. It has two
partners GABPB-1 and GABPB-2, to form a hetero-tetramer bound to DNA (141). The tetrameric
interface forms a GABPA-(GABPB)2- GABPA. However, the structure of this trimeric complex,
as well as knowledge of its ability to distinguish specific sites in promoters, have not been
determined yet.
The dimerization of the ETS members has been proven to regulate DNA binding as well
as phosphorylation mechanisms. However, thus far, the only members characterized have
contained additional well-structured regions, either adjacent to the ETS domain (ex: HI-1/HI-2 of
ETS-1) or the whole PNT domain. It is in our interest to study members that only have the ETS
domain structured and the rest of the protein intrinsically disordered. Will the intrinsically
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disordered regions of these proteins have the same effect as the structured regions in mediating
dimerization and therefore regulating gene expression?
1.5

Transcription factor PU.1
ETS family member PU.1 was first discovered in 1988 (142). It encodes for the spi1 gene

in humans and the spfi1 gene in mice. (131). Its name derives from PU-box binding-1 as the protein
binds to a purine-rich region “PU-box” of nucleotides GGAA (143). PU.1 has 270 residues in
humans [Figure 1.6]. The ETS domain is made of ~85 residues near the C-terminus, while adjacent
to the ETS domain on the N-terminus is the PEST domain that is composed of 48 residues. This is
followed by a Q-rich region of about 35 residues and the transactivation region (TAD) of 80
residues. PU.1 only has its ETS domain as a well-folded domain, while the rest of the protein is
disordered and tethered around the DNA binding domain.
1.5.1

Biological role PU.1 transcription factor and diseases

A knockout technique of the spfi1 gene has been used to study the function of PU.1. Many
knockout alleles of the spfi1 gene have been generated and analyzed throughout the years (144149), demonstrating that PU.1 is critical to generate B cells, macrophages, dendritic cells, and
neutrophils. PU.1 is partially critical in generating T cells and erythroid cells and not important at
all for the production of megakaryocytes. In addition to the knockout experiments, “knock-in”
experiments have also been performed in the spfi1 locus in mice to analyze the expression of PU.1.
(112,150-153). These studies showed that PU.1 expressed the highest in the myeloid linage in a
tissue-specific manner. PU.1 expression is controlled in a dosage depended manner increasing
during granulocytes-macrophages differentiation and decreasing during megakaryocytes and
erythrocytes. In summary, PU.1 plays a critical role in regulating the differentiation of
hematopoietic lineages (lymphoid and myeloid), and it's highly expressed in immune systems
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cells, particularly for the production of B cells (154). Disruption of PU.1 regulation leads to many
diseases such as lymphomas, leukemia, myeloma, Alzheimer’s disease, and tissue fibrosis (155),
making PU.1 an attractive therapeutic target. Thus far, the Poon lab, in collaboration with other
labs, has worked at pharmacological mediations in targeting PU.1 with therapeutic compounds for
fibrotic diseases and acute myeloid leukemia (156-158).
1.5.2

Hydration in PU.1

Emerging evidence also links the ETS family to the hydration theory with the heterogeneity
of DNA targets (159). Many ETS members DBD have been solved by crystallography bound to
their respective high-affinity DNA and deposited in the protein data bank (PDB). Interestingly
when observing these co-crystals, we can see that some proteins such as PU.1 have a high
abundance of interfacial water-mediated contacts in comparison to other co-crystals such as ETS1 (143,160). The difference between PU.1 and ETS-1 continues as the two proteins are the most
phylogenetically distant class of ETS proteins (109). Considering that ETS-1 is a more ancient
protein (161) and it has fewer water contacts between its DBD and DNA while PU.1 has a large
amount of water-mediated contacts suggests that hydration could be an evolutionary trait of the
ETS family. The water-mediated contacts by PU.1 are replaced by direct contacts by ETS-1. This
fact raises the question of whether PU.1 has a regulatory mechanism that involves hydration.
The Poon lab, in collaboration with the Wilson lab, has worked on this same question for
many years to establish how hydration plays a role in PU.1 regulation. Experiments in which both
PU.1 and ETS-1 bound to DNA (high affinity and low affinity) undergo osmotic stress by various
physiologically compatible osmolytes have been performed (162) as well as swapping structural
elements of one protein to another (78) to assess their reaction to osmotic stress. The data has
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revealed that PU.1 is indeed osmotically sensitive when bound to high-affinity DNA while ETS-1
is not.
This brings us to a new question regarding PU.1 hydration mechanism: what residues are
responsible for the osmotic sensitivity? In chapter 2 we address this same question as both PU.1
and ETS-1 (along with the whole family) have a handful of residues that have the same orientation
when bound to DNA. We wanted to mutate a highly conserved residue in the family to see the
effects of hydration in both paralogs.
1.5.3

Dimerization of PU.1

PU.1 structure bound to DNA (1:1) has already been solved (143) and it is presumed to be
the active state of PU.1. However, previous work by the Poon lab has shown that PU.1 can
dimerize at a single cognate DNA binding site (2:1) (163,164). This property of PU.1 dimer on
one single cognate DNA is interesting as no other ETS member has demonstrated it thus far.
Biophysical data indicates that PU.1 forms a sequential dimer as a potential negative feedback
mechanism in the absence of inhibitory cofactors such as GATA-1 (164). This information gives
an insight into how PU.1 self-regulates its activity and a new way of ETS proteins controlling their
genes. In Chapter 3 we demonstrate how this self-sufficient mechanism regulates PU.1.
1.5.4

Using X-Ray Crystallography for protein structure

Over 125 years ago Wilhelm Roentgen discovered X-rays and almost two decades later
Max von Laue showed x-ray diffraction patterns of crystals (165). Soon after William Lawrence
Bragg derived the equation that describes the principle of image formation by X-Ray diffraction
(166). William Lawrence Bragg and his father William Henry Bragg won a Nobel Prize in
Physics in 1915 "For their services in the analysis of crystal structure by means of X-rays."
𝑛𝜆 = 2𝑑 sin Ѳ

(10)
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[Figure 1.8A] shows the diagram of Equation 10 where two waves in phase with each
other are separated by a distance (d) between the atomic planes. Crystallography is a technique
that is highly favorable in getting a molecular structure from a crystal that diffracts when exposed
to an X-ray beam. The diffracting pattern is used as a map to determine the symmetry and the size
of the protein. The intensity of the spots diffracted help construct an electron density map (heavy
atoms have more density) to build a molecular structure of the protein from amino acids. Finally,
the structure is refined to adopt the most favorable conformation (167).
X-ray crystallography has developed into one of the most powerful structure determination
tools for protein, DNA, viruses, and organic/inorganic material. This year alone (2020), there are
more than 7000 x-ray structures deposited in the Protein Data Bank: 5x more than electron
microscopy (EM) and 29x more than NMR.
For the purpose of this thesis I am going to focus on protein: DNA complexes. The first
step of getting crystals is the purification and screening techniques of the right condition. In [Figure
1.8B] the Art Robbins Gryphon LCP crystallization system uses the Index and JCSG screening
kits from Hampton Research to screen potential conditions for crystallization of PU.1/DNA
complex. We set out to crystalize PU.1 and DNA in a 1:1 complex at a higher resolution then
previously resolved for in depth data analysis. I will cover the findings and significance of the cocrystal structure in Chapter 4 for more detail. After finding the correct conditions we set to
optimize them for better results utilizing the hanging-drop method (168) [Figure 1.8C-D]. Days
after the hanging-drops were set, crystals started to form [Figure 1.8E]. An interesting fact should
be mentioned at this point that there is no correlation between the appearance of the crystal under
the microscope with its capability to diffract (168).
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To acquire the data the crystal gets bombarded by X-rays from synchrotron radiation which
can vary in wavelengths from 0.5- 3.0 Å, depending on the size of the crystal (168). The diffraction
is recorded by a detector and then is subjected to data analysis. From the diffraction pattern one
can determine the unit cell dimensions which is the smallest repeating unit. The measurements of
the unit cell are calculated from the spacing of the spots from the diffraction pattern and given in
lengths (a, b and c) and angles (α, β and γ) (167). The data then gets scaled according to amplitude
(to relate the intensities of each data point) (167) and then phased by isomorphous replacement
(169) or the molecular replacement method (170). For the PU.1:DNA complex, Xray Detector Software (XDS) is used for amplitude scaling and phasing was done by molecular
replacement in Python-based Hierarchical ENvironment for Integrated Xtallography (Phenix). The
amplitude and phasing data is then used to reconstruct an electron-density map which is limited
by its resolution. Resolution is dependent upon the distance between the atomic planes [ e.i Figure
1.8A], the crystal packing, the brightness of the x-ray radiation source, and the detectors sensitivity
(171).
It is important to remember that crystal structures are snapshots of a refined average
conformation frozen in time (165). In biological solutions these proteins and/or protein: DNA
complexes are more dynamic and could occupy more distinct conformations. Here, is where
crystallography fails to determine the dynamic nature of macromolecules. Along that line
intrinsically disordered regions (IDRs) of proteins do not show up on the density map due to their
intrinsic flexibility. In these cases, NMR techniques are used to determine the dynamic solution
structure of proteins and/or molecular dynamics (MD) simulations to capture conformational
changes (165,172).
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Figure 1-1 The central dogma of molecular biology
A The replication step is when a cell is involved in making a copy of its genomic information
before it divides. B, the transcription step is in which the information of the gene required will be
transcribed into portable messenger RNA (mRNA) by RNA polymerase II. C, the portable mRNA
leaves the nucleus for the cytoplasm with the destination to the ribosome. D, the ribosome reads
the mRNA and translates the information into making proteins. These proteins will undergo posttranslation modification before carrying their function into the body
.
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Figure 1-2 Initiation of transcription
The first step in transcription is called initiation, it involves a variety of transcription elements.
Once the signal is given and a transcription factor (either activator or repressor) binds to its target
DNA binding region called the enhancer region (orange) will then set in motion the initiation
cascaded of events. The TATA-binding protein (TBP in mustard yellow) will bind to the TATA
region (dark blue) that is located in the promoter (~100 bp in bright yellow) and will induce a 90 o
bend in the DNA. This then recruits the general transcription factors TFIIA, TFIIB, TFIID, TFIIE,
TFIIF, and TFIIH (color breakdown insert in the figure) which will bind to specific promoter
sequences to recruit RNA polymerase II (red) to initiate transcription. A mediator (purple) is then
added to maintain the pre-initiation complex (General TF and RNA pol II) to transmit signals
between the transcription factors and the polymerase (173) This figure was made by inspiration
from(174) (175)
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Figure 1-3 The most common transcription factor DNA binding motifs
Representation of the different motifs is in (green) bound to their respective DNA (light brown).
The Zinc-finger representative is transcription factor Kaiso which is stabilized by a Zn +2 ion (blue)
that gives the family its name. The second transcription factor is HOX-B1 that belongs to the
Homeobox family. The whole domain is made of the three-helices bundle, two are parallel to one
another and the third recognizes DNA. The next representative is transcription factor CAP with a
helix-turn-helix motif. This motif involves the helix that recognizes DNA and a turn that connects
it to another helix. The following representative is transcription factor TCF4 belonging to the basic
helix-loop-helix motif. This motif is identified by two helices mediating DNA recognition and
connected by a loop. Next is the transcription factor CREB with the basic leucine zipper motif.
The interaction of the two helices is held in place by leucine residues that form hydrophobic stable
interactions when bound to DNA. Lastly, there is the transcription factor PU.1 representing the
winged helix-turn-helix motif. The characteristic of this motif is the insertion of one helix into the
major groove and it is connected by a turn with another helix and connected on the other side by a
beta-sheet creating a floppy “wing”. All the structures were taken from the PDB (176) and the
figure was created using Pymol (The PyMOL Molecular Graphics System, Open Source,
Schrodinger, LLC

27

Figure 1-4 Transcription factors have an abundance of intrinsically disordered regions
A schematic representation of a narrowing down the different types of transcription factors. Type
I incorporates the transcription factors that only have their DBD well-structured and the rest of the
protein is disordered both on the N-terminus and the C-terminus of the DBD. The example shown
is of PU.1 a transcription factor belonging to the ETS family. Type II incorporates all the
transcription factors that have another or many other domains that are well structured in addition
to their DBD. The example given is of ETS-1 of the ETS family indicating that proteins of the
same family can have different architecture. Figure inspired by (45)
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Figure 1-5 The ETS family of transcription factors
The representation of the ETS family demonstrated by the 12 subfamilies and the 28 members.
The schematic representation of the length and the domain position of the ETS in blue and the
PNT in green have been inspired by (109)
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Figure 1-6 A closer look at transcription factor PU.1
A is the detailed schematic of PU.1 representing the different regions of the protein. In blue is the
ETS domain and in gray are the disordered regions divided by the specific names of the domains,
TAD, Q-rich, and PEST domain (155). B is the zoomed-in PDB of PU.1 (1PUE) (143) that has a
wHTH motif as the Helix 3 is inserted into the major groove making contact with the consensus
GGAA nucleotides (orange)
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Figure 1-7 Protein dihedral angles
The peptide backbone can rotate by the N-Cα bond called ϕ and by the Cα-C bond called ψ. The
bond angles of the proteins can be plotted in Ramachandran plot deriving its name from the
scientist that discovered it, G. N Ramachandran, in 1963. Torsion angles are among the most
important feature indicating protein folding. The torsion angles determine the conformation of the
residues (in blue) where the typical secondary structure of alpha-helix and beta-sheet clusters of
the protein would be. The lighter blue regions indicate residues that are allowed to come closer
together and yet they don’t have a defined secondary structure (random coil). Many conformations
however are not possible due to steric hindrance (yellow). The figure was inspired by (177)
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Figure 1-8 PU.1/DNA complex crystals settings
A: The diagram of two waves in phase with a distance (d) between the atomic plates. The angle
Ѳ is the reflected angle and the path between points C, B and D be a whole number (n= 2 above)
of wavelengths (λ). The distance from C-B is the same as B-D therefore we get Braggs equation
nλ= 2dsin Ѳ. The figure is inspired from Encyclopedia Britannica. B. The robot screening
conditions for PU.1: DNA complex. C. Ross Terrell (collaborator from Ming Luo’s lab) setting
hanging drops of PU.1: DNA complex. D. Cartoon of vapor diffusion hanging-drop mode. E.
Crystals of PU.1: DNA complex
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DISTINCT ROLES FOR THE INTERFACIAL HYDRATION IN SITE-SPECIFIC
DNA RECOGNITION BY ETS-FAMILY
Copyright © 2017 American Chemical Society [The Journal of Physical Chemistry B
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2.1

Abstract
The ETS family of transcription factors is a functionally heterogeneous group of gene

regulators that share a structurally conserved, eponymous DNA-binding domain. Unlike other ETS
homologues, such as Ets-1, DNA recognition by PU.1 is highly sensitive to its osmotic
environment due to excess interfacial hydration in the complex. To investigate interfacial
hydration in the two homologues, we mutated a conserved tyrosine residue, which is exclusively
engaged in coordinating a well-defined water contact between the protein and DNA among ETS
proteins, to phenylalanine. The loss of this water-mediated contact blunted the osmotic sensitivity
of PU.1/DNA binding, but did not alter binding under normal-osmotic conditions, suggesting that
PU.1 has evolved to maximize osmotic sensitivity. The homologous mutation in Ets-1, which was
minimally sensitive to osmotic stress due to a sparsely hydrated interface, reduced DNA-binding
affinity at normal osmolality but the complex became stabilized by osmotic stress. Molecular
dynamics simulations of wild type and mutant PU.1 and Ets-1 in their free and DNA-bound states,
which recapitulated experimental features of the proteins, showed that abrogation of this tyrosinemediated water contact perturbed the Ets-1/DNA complex not through disruption of interfacial
hydration, but by inhibiting local dynamics induced specifically in the bound state. Thus, a
configurationally identical water-mediated contact plays mechanistically distinct roles in
mediating DNA recognition by structurally homologous ETS transcription factors.
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2.2

Introduction
The ETS family of transcription factors binds site-specific DNA via eponymous,

structurally conserved DNA-binding domains that share low sequence homology. To date, a
plethora of co-crystals of site-specific binary ETS/DNA complexes, as well as ternary structures
in combination with other protein binding partners, show a highly conserved binding mode in
which a recognition helix is inserted into the major groove of target DNA harboring the core
sequence 5′-GGAA/T-3′, with additional interactions along the DNA backbone at flanking minor
groove positions. Despite the apparent homogeneity at the macromolecular level, heterogeneous
levels and patterns of hydration pervade the protein/DNA interface. For instance, in the cocrystal
of the PU.1 ETS domain with site-specific DNA, the contact interface is densely hydrated with
several interfacial residues engaging in exclusively water-mediated contacts with the target DNA
(143). In contrast, the cocrystal structure for Ets-1 shows a sparsely hydrated interface where most
of the corresponding residues make direct contact with the DNA (160). The differences in
crystallographic hydration between the two ETS domains, whose backbone trajectories are
superimposable in the DNA-bound complex, have been reproduced in solution studies that
perturbed ETS/DNA binding by osmotic pressure (162,178). These hydration differences are
profoundly correlated to their binding kinetics, conformational dynamics, and site discrimination
(179). In turn, target discrimination by ETS homologues, all of which share overlapping DNA
sequence preferences (110), continues to be a major area of interest in understanding how
biological specificity is achieved in vivo (180,181). Since the topology of the ETS/DNA contact
interface is highly conserved among ETS homologues, differences in conformational dynamics
are presumably important in determining the hydration of ETS/DNA complexes. While such
differences have been observed globally in ensemble experiments by dynamic light scattering,
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structurally resolved data do not yet exist. To address the correlation between interfacial hydration
and conformational dynamics of ETS/ DNA complexes, we targeted conserved ETS residues
involved only in water-mediated contacts and not any other direct interactions with either itself or
the DNA. In PU.1, the side chain −OH of Tyr252 coordinates a bridging water with a universally
conserved arginine (Arg235) and a backbone phosphate of the target DNA. This is a universally
conserved configuration of interfacial hydration in all ETS homologues, including Ets-1, that
harbor this equivalent Tyr. We mutated this Tyr in both PU.1 and Ets-1 and compared their DNA
site recognition under osmotic pressure as well as in silico by molecular dynamics simulations.
The two orthogonal approaches provide a deeper insight into the mechanism of DNA recognition
with respect to the absence of extensive interfacial hydration of Ets-1 (and sequence-similar
homologues such as Ets-2, Fli-1, and GABPα) versus PU.1 (and its phylogenetic relatives such as
ETV6).
2.3

Results
Despite a well-defined structural homology in terms of backbone trajectories, and

overlapping DNA sequence tolerance, the DNA-binding domains of ETS transcription factors are
divergent in amino acid sequence. Of the limited set of residues that are strictly or highly
conserved, most are engaged in direct protein-to-DNA contacts, and alanine scans typically abolish
DNA binding. The role of other conserved residues, such as an interfacial tyrosine near the Cterminus in the primary sequence of ETS domains [Figure 2.1A], has been less clear. This tyrosine
is found in 26 of the 28 known murine (and human) ETS homologues, and all co-crystals of these
homologues show a water-mediated contact coordinating the side chain −OH of the tyrosine, a
universally conserved arginine in the recognition helix, and the backbone phosphate of the base
upstream from the 5′-GGAA-3′ core consensus. Moreover, this well-defined water-mediated
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“motif” is conserved whether the interface is otherwise extensively hydrated (such as in PU.1)
(143) or not (such as in Ets-1) (160) [Figures 2.1B−G].
The strong conservation of this exclusively water-coordinated tyrosine among ETS
homologues suggests that it plays an important role in mediating ETS/DNA binding. In the
cocrystal structure of PU.1, this tyrosine anchors one end of an extensive interfacial water network,
and its mutation to phenylalanine (loss of the side chain −OH) represents an attractive approach to
probing this water network. We therefore mutated this Tyr to Phe in the ETS domain of PU.1
(PU.1ΔN167) and Ets-1 (Ets-1ΔN331) [Figure 2.2A], and compared their recognition of optimal
site-specific DNA under normal-osmotic and osmotically stressed solution conditions relative to
their wild type counterparts
In previous studies,(162,178) we have extensively characterized the perturbative effects
of compatible co-solutes on DNA binding by the ETS domains of both PU.1 and Ets-1. Using a
palette of co-solutes spanning a broad range in physical chemistry, such as betaine, disaccharides
(sucrose, maltose), and glycols (triethylene glycol), we observed that their effect on site-specific
binding affinity correlated only with their osmolality over an extended range of co-solute
concentrations. The key conclusion from this colligative behavior is that the co-solutes did not
exhibit co-solute specific preferential interactions with the macromolecules and that their
perturbations on binding could be interpreted in terms of hydration changes upon
binding..(93,100,182,183) For our studies here we used betaine, a physiologically compatible
osmolyte, out of convenience given its relatively neutral effect on bulk viscosity and dielectric
constant.
We carried out competitive fluorescence polarization titrations of ETS-bound, TYE 563labeled DNA probe with an unlabeled competitor (harboring the optimal sequence for each
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respective protein) with or without graded concentrations of betaine [Figure 2.2B]. The data was
analyzed with a mechanistic model (184) to estimate the absolute binding constant (not IC50’s)
for the unlabeled complex of interest. The in-solution affinities for wild type PU.1 and Ets-1 show
quantitative agreement with previous values obtained by electrophoretic mobility shift (162,178)
and surface plasmon resonance (185,186).
2.3.1

Mutation of a Conserved Interfacial Tyrosine Inducing Markedly Diﬀerent
Eﬀects on DNA Recognition by the Structurally Homologous ETS Domains of
PU.1 and Ets-1

Measurement of the apparent dissociation constants for the wild type and mutant
PU.1ΔN167 and Ets-1ΔN331 showed that both mutants retained high-affinity binding to their wild
types’ optimal DNA targets (KD < 10 −8 M) under normal-osmotic conditions (150 mM Na+, 0.29
osmolal). However, osmotic stress to 2.5 osmolal showed distinct mutational effects on the affinity
and osmotic sensitivity of DNA recognition by the ETS homologues.
In the case of PU.1, both wild type and mutant protein were negligibly different in their
affinities for high-affinity site-specific DNA, but the mutant bound its target more strongly than
wild type with increasing osmotic pressure. Over the measured range of osmotic pressure, the
osmotic dependence (slope) of the binding affinity was ∼25% lower in magnitude for the
PU.1ΔN167Y252F mutant than wild type PU.1ΔN167 [Figure 2.2C], consistent with a deficit of
interfacial hydration in the mutant/DNA complex relative to wild type. Quantitatively, the effect
was more pronounced than if the nine water-mediated contacts seen in the cocrystal structure
contributed equally to the binding free energy. In stark contrast to PU.1, the ETS domain of Ets-1
exhibited altogether different behavior when probed by osmotic pressure. At normal-osmotic
pressure, binding of Ets-1ΔN331Y412F to high-affinity site-specific DNA was ∼60-fold weaker
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relative to wild type, although still >10-fold stronger than nonspecific binding (187). As observed
previously, (162) unlike PU.1, the site-specific complex of wild type Ets-1ΔN331 was slightly
stabilized by osmotic pressure. In comparison, the osmotic dependence of the affinity (slope) for
Ets-1ΔN331Y412F was ∼35% more positive than wild type, inferring relative dehydration of the
mutant Ets-1/DNA complex relative to wild type.
As binding affinity reflects the free energy change of the components from the unbound to
bound state, differential perturbations of the mutations on the unbound proteins may also
contribute to heterogeneity in DNA binding. Therefore, we probed wild type and mutant
PU.1ΔN167 and Ets-1ΔN331 in the absence of DNA by circular dichroism spectroscopy to
determine the secondary structure contents of each construct at 25 °C under normal-osmotic
conditions [Figure 2.3A] and measured their stability by thermal melting [Figure 2.3B].
Decomposition of their CD spectra showed an apparent loss of 15 to 20% β-sheet in both mutants
relative to wild type [Table 1], which was the secondary structure at the mutated positions. Despite
this difference, wild type and mutant PU.1ΔN167 unfolded reversibly with experimentally
indistinguishable melting temperatures and enthalpy changes. In contrast, Ets1ΔN331Y412F
unfolded at a higher melting temperature than wild type by ∼8 °C. Although thermal denaturation
was not reversible for either Ets-1 construct, as previously noted (188), the alignment of the signal
in the cooling run with the post transition baseline of the heating run for both Ets-1 constructs
indicated that irreversible change occurred after denaturation. Since Ets-1 harbored free cysteine
(but not PU.1), we confirmed by size-exclusion chromatography that the mutations did not cause
protein oligomerization under the solution conditions of the CD experiments [Figure 2.3C]. All
wild type and mutant constructs eluted quantitatively as a single species according to their nominal
molecular weight (∼13 kDa, at a higher elution volume than myoglobin at 17 kDa). To further
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probe the structural differences between wild type and mutant Ets-1ΔN331, we acquired and
compared their 1H−15N HSQC NMR spectra [Figure 2.3D], which showed complete or partial
overlap of >90% of resolved resonances. Using the solution NMR structure of Ets-1ΔN301 (188),
about half of the peaks showing the largest shifts (partial or complete) are ±20 residues from the
mutated position (Y412). Thus, wild type and mutant Ets-1ΔN331 showed substantially similar
folding but exhibited some local and distal conformational changes in the unbound state.
In summary, one-atom mutation of a highly conserved interfacial Tyr to Phe produced
distinct effects on the DNA binding and conformational properties of the ETS domains of PU.1
and Ets-1. This heterogeneity was unexpected given the strong structural homology of the two
ETS domains in general (109), an identical configuration in coordinating a water-mediated contact
in their cocrystal structures [cf. Figures 2.1F and 2.1G], and the similar solvent-accessible topology
of the mutated Tyr.
2.3.2

Molecular Dynamics Simulations of Wild type and Mutant ETS Domains of
PU.1 and Ets-1 Recapitulated Experimental Data.

While the free (188) and DNA-bound (160,189) structures of the Ets-1 ETS domain are
known, only the DNA bound PU.1 structure1 currently exists. To understand the experimental
differences among - and mutant PU.1 and Ets-1 in greater detail, we carried out all-atom molecular
dynamic simulations of the four constructs in their free and site-specifically DNA-bound states.
Unbound Ets-1 was taken from a crystallographic structure (PDB: 1GVJ) and unbound PU.1 from
the cocrystal structure. The protein/DNA complexes were constructed by modifying the cocrystal
structures to match the experimental sequences. All crystallographic water molecules were
retained and treated as TIP3P water. Following equilibration in explicit solvent containing 0.15 M
NaCl, and confirming that the crystal waters at the interface in the complexes had not exchanged
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with bulk solvent, each system was simulated to convergence as indicated by RMSD from the
initial coordinates [Figure 2.4, parts A and B, for unbound proteins, 100 ns]. Enumeration of Hbonds with solvent showed identical hydration between wild type and mutant unbound PU.1
(within 1%) in agreement with their similar melting temperatures and unfolding enthalpies [Figure
2.4C]. However, wild type Ets-1 showed >4% (average) more solvent H-bonds than the mutant,
indicating less solvent exposure in the mutant [Figure 2.4, parts C and D] and consistent with its
relative thermal stability over wild type Ets-1 [cf. Figure 2.3B]. In addition, the shallower slope of
the mean square displacement with respect to time (which is proportional to the self-diffusion
constant) for wild type Ets-1 (0.2 × 10−9 m2 /s) relative to wild type PU.1 (0.6 × 10−9 m2 /s) [Figure
2.4, parts E and F] recapitulated published dynamic light scattering measurements showing a 14%
larger hydrodynamic radius for Ets-1ΔN331 over PU.1ΔN167 (179).
In the case of the DNA-bound complexes (200 ns simulations), both wild type and mutant
complexes formed by PU.1 with its 14-bp DNA remained well-behaved through the simulation.
However, the wild type complexes formed by Ets-1 with a 14-bp site-specific target exhibited
significant fraying at the DNA ends and interactions between the protein and the frayed ends. To
account for this, both wild type and mutant Ets1 complexes were re-simulated with longer DNA
duplexes matching the full 23-bp experimental construct. Bases proximal to the protein remained
duplex throughout the simulations with the longer DNA. Although the wild type and mutant
complexes for both ETS homologues did not differ significantly in terms of RMSD from the initial
coordinates [Figure 2.5A], there was a substantial bias in dynamic fluctuations in favor of wild
type over mutant Ets-1 complexes. Comparison of the per-residue RMS fluctuations (RMSF;
standard deviations from average positions) of the DNA-bound states indicated significant local
dynamics in wild type Ets-1 over the Y412F mutant [Figure 2.5B]. The average excess RMSF
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(wild type over mutant) was +0.025 nm per residue for Ets-1 and lower than +0.01 nm for PU.1.
To evaluate the validity of the simulated dynamics, we examined the available solution NMR
structures of free (188) and DNA bound Ets-1 (189). The experimental structures show excess
dynamics in DNA-bound Ets-1 that are localized in elements contacting the minor groove DNA
backbone flanking the 5′- GGAA-3′ core consensus, as well as two loops distal from DNA binding
interface [Figure 2.5C].1 Although the agreement was not quantitative, the simulations correctly
reproduced the presence and positions of the induced experimental dynamics in DNA-bound Ets1. These dynamic hotspots were discontinuous in primary sequence, clustering primarily in the Nterminal half and distally from C-terminal position of Tyr412, indicating that the dynamics were
transmitted through the protein’s tertiary structure and probably through the DNA “substrate.” In
summary, the simulations’ agreement with the experimental data for wild type PU.1 and Ets-1
reported here and by others provided evidence that the simulations semi quantitatively described
the solution behavior of the proteins in their free and bound states.
2.3.3

Hydration Dynamics in the Wild type and Mutant Phe-to-Tyr PU.1 and Ets-1
Complexes.

To probe interfacial hydration in the simulated structures, H-bonds formed by solvent to
protein and nucleotide bases participating in water mediated contacts in the contact interface were
enumerated for each system based on combined distance and angle criteria from triplicate
independent production runs [Figure 2.6]. The hydration of the tripartite water-mediated contact
in the crystal structures was evaluated using the functional groups involved: the side chain −OH
of Tyr252/Tyr412 (PU.1/Ets-1), the guanidinium N of Arg235/Arg394 (PU.1/Ets-1), and the backbone
phosphate at the −1 position (relative to the 5′- GGAA-3′ core consensus). To assess interfacial

1

See also Addendum at the end of this Chapter, Section 2.7.
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hydration more generally, the number of solvent H-bond contacts made by guanidinium N of
Arg235/Arg394 and the major groove-facing heteroatoms of the nucleobases in the 5′-GGAA-3′ core
consensus (i.e., O6 and N7 for G; N7 and N6 for A; O4 in T, and N4 in C) were also calculated. While
these groups represent only a subset of all the interfacial residues, they are fully conserved between
PU.1 and Ets-1, providing a chemically fair and equivalent basis for comparison between the two
systems. Starting from the interfacial hydration observed in the PU.1/ DNA cocrystal structure,
the number of solvent H-bond contacts made by the wild type complex remained steady throughout
the simulation. In particular, the 4-OH group of Tyr 252 was associated with a time-averaged value
of ∼0.9 solvent H-bond, consistent with its role in coordinating the tripartite water-mediated
contact with Arg235 and a DNA backbone phosphate as observed crystallographically. Without the
tyrosyl 4-OH group, hydration of Arg235, the phosphate at the −1 position, and the 5′-GGAA-3′
interface all became partially depleted in the mutant complex. Nonetheless, the deficit of solvent
H-bonds for interfacial residues in the mutant PU.1 complex did not significantly exceed the loss
(∼1 contact) already accounted for by Arg235, which was present in both sets of residues. Depletion
of interfacial hydration in the PU.1/ DNA complex due to the Y252F mutation therefore appeared
to be limited primarily to the loss of water associated with the tyrosyl 4-OH group. In the case of
wild type Ets-1, the time-averaged hydration at Tyr412 was significantly lower (<0.3 H-bonding
contact) relative to PU.1 despite an identical conﬁguration of water-coordinating residues,
suggesting that the tripartite water-mediated contact was less persistent in Ets-1 compared to PU.1.
In agreement with the cocrystal structures, hydration at the 5′-GGAA-3′ interface in the wild type
Ets-1 complex was also lower, at down to half the level observed in the wild type PU.1 complex
[cf. Figure 2.1, parts D and E]. However, abolishing the tyrosyl 4-OH contact in the Y412F mutant
did not signiﬁcantly perturb the hydration near the residue or in the ETS-1/DNA interface,
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suggesting that, like the mutant PU.1/DNA complex, any dehydration was also limited to the
mutated residue.
2.3.4

Structural Interpretation of Interfacial Phe-to-Tyr Mutations on Aﬃnity and
Osmotic Sensitivity of DNA Binding.

Osmotic stress experiments showed that loss of a conserved, interfacial H-bond donor in
PU.1 and Ets-1 generated altogether different responses to osmotic pressure in their DNA
complexes. In PU.1, whose wild type high-affinity DNA complex was profoundly destabilized by
osmotic stress, the Y252F mutant was less sensitive. In Ets-1, the wild type complex was
essentially insensitive to osmotic stress, but the Y412F mutant became more sensitive in the
direction of increased water release. However, the experiments also showed that DNA recognition
by PU.1 under norm-osmotic conditions were not affected by the partial loss of interfacial
hydration in the mutant, whereas affinity for Ets-1 was reduced. The simulations provided a
structural correlation in terms of induced localized dynamics in the wild type Ets-1/DNA complex,
which agreed semi quantitatively with experimental NMR data of free and DNA-bound Ets-1 (cf.
Figure 2.5C). If induced dynamics in the bound state are specific to Ets-1, as consistent with
thermodynamic observations that site-specific Ets-1/DNA binding is more entropically driven than
for PU.1 (162), the dampened fluctuations exhibited by the Y412F mutant would reduce the
favorable entropic contribution to its binding affinity. Excess dynamics in the DNA-bound state
would also contribute to the skewing of osmotic sensitivity toward water release for the Y412F
mutant, because hydration of dynamic elements with increased solvent exposure in the wild type
complex would be absent in the mutant complex. Thus, the analogous Tyr-to-Phe mutation in PU.1
and Ets-1 reveals different selection pressures at work (osmotically sensitivity for PU.1 vs
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dynamics induction for Ets-1) in the divergent evolution of ETS homologues, while maintaining a
highly conserved fold characteristic of this family of transcription factors.
2.4

Discussion
Mutation of a single conserved tyrosine that comprises an exclusively water-mediated

interfacial contact with site-specific DNA, to phenylalanine, causes markedly heterogeneous
effects on the affinities of the ETS domains of PU.1 and Ets-1. In addition to dissimilar effects on
DNA recognition under norm-osmotic conditions, osmotic stress reveals disparate disposition of
hydration water between the two structural homologues. In this study, molecular dynamics
simulations provided a high-resolution interpretation of the experimental data. To this end, the
constructs and conditions of the simulations were configured to match experimental (normalosmotic) conditions as closely as possible using extant structural data as templates. The extensive
agreement of the simulations with experimental data reported here and by others from CD
spectroscopy [cf. Figure 2.3], dynamic light scattering, (179) titration calorimetry, (162), and
solution NMR [cf. Figure 2.5]) provided confidence that the force field (CHARMM36) and the
results represent an accurate semi quantitative description of ETS/DNA interactions
2.4.1

PU.1 Tuned to Optimize Sensitivity to the Osmotic Environment in DNA
Recognition.

One of the most intriguing features of the PU.1ΔN167Y252F mutant is its recovery from
partial loss of interfacial hydration to bind site-specific DNA equally as tightly as wild type PU.1
under norm-osmotic conditions. This unexpected observation suggests that alternative, less
hydrated binding modes are accessible to PU.1. However, to what extent are interfacial hydration
configurations adaptive? The very few ETS homologues that harbor a Phe at the corresponding
Y252 position in PU.1 offer an insight. In the cocrystal structure of ETV6 (190), which binds target
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DNA sites equally as well as any other ETS domain (10−10 to 10−9 M under norm-osmotic
conditions), Phe395 is the wild type residue at the corresponding Tyr252 and Tyr412 position in PU.1
and Ets-1 [cf. Figure 2.1A]. Similar to PU.1, the ETV6/ DNA interface is well hydrated, albeit in
a different configuration by one fewer than the hydration network in the wild type PU.1/DNA
interface. It is also significant that ETV6 is the closest phylogenetic relative of PU.1 (but less distal
from Ets-1) (109), suggesting that biological mechanisms may exist that discriminate specific
levels of interfacial hydration in cognate ETS/DNA complexes.
Functionally, PU.1ΔN167Y252F binds as well as wild type to site-specific DNA in the
absence of osmotic stress. On the basis of affinity alone, it would seem that the wild type protein
is at best functionally neutral with respect to the Y252F mutant under norm-osmotic conditions.
What may be a selective advantage of wild type PU.1? The evolutionary maintenance of the wild
type as a more osmotically sensitive phenotype, in light of the hydration properties of ETV6,
suggests that responsiveness to osmotic pressure is a functional advantage for PU.1. Biologically,
PU.1 is a lineage-restricted transcription factor and critical regulator of hematopoiesis, the
multistep process by which stem and progenitor cells in bone marrow self-renew and differentiate
into terminal lineages of blood cells (145,150,191-193). As physiological osmotic stress has been
established in lymphoid tissues in vivo (194) due to the very high metabolic rate within rapidly
dividing cells, (195) an emerging hypothesis is that strong osmotic responsiveness by PU.1 may
be a favorable regulatory phenotype. We have previously discovered through a bioinformatics
analysis that PU.1 targets are over-represented among known osmotically sensitive genes (162).
The present mutagenesis data indicating that DNA binding by PU.1 is biophysically optimized for
osmotic sensitivity lends further support to this hypothesis.
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2.4.2

Role of Interfacial Hydration in DNA Recognition by ETS-1.

In stark contrast with PU.1, the loss of the analogous Tyr412 water-mediated contact in Ets1 reduces its DNA binding affinity (though >10-fold above nonspecific levels) (187) under normosmotic conditions. Thermal denaturation of wild type and mutant proteins in the absence of DNA
showed that the Tyr-to-Phe mutation was more perturbative to the conformational stability of
unbound Ets-1 than PU.1 [cf. Figure 2.3B]. Molecular dynamics simulations suggested that the
Y412F mutation in Ets-1 dampened dynamic fluctuations in the free protein, as judged by
differences in their relative hydration and diffusive properties [cf. Figure 2.4, parts D and F], and
attenuated induced fluctuations in the DNA-bound state that appeared to be crucial for Ets-1
binding. Thus, the interfacial tyrosine in Ets-1 (Y412), even though it shows the same hydration
pattern as PU.1 (Y252), is not directly linked to hydration, but rather part of the structural dynamics
that are specific to Ets-1. This interpretation is consistent with experimental dynamics from
solution NMR of free and unbound Ets-1, titration calorimetry (Ets-1/DNA binding being more
entropically driven than PU.1) (162), and the skewing of osmotic sensitivity toward water release
by the Y412F mutant (abrogation of hydration of dynamic elements in wild type Ets-1). Strong
dynamics in the N-terminal helices have also been reported in a previous molecular dynamics
study of DNA-bound wild type Ets-1 (196), but that study did not include a paired simulation of
the unbound protein or any mutant for comparison. Taken together, the structural observation that
Ets-1/DNA interface is sparsely hydrated and maintained primarily by direct contacts between
protein and DNA (160,162) should now be understood mainly in terms of induced dynamics in the
DNA-bound state, rather than the lack of an adhesive role for interfacial water-mediated contacts
as with PU.1 and its proximal phylogenetic ETS relatives.
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2.5

Conclusion
By way of mutating an interfacial water-coordinating tyrosine that is highly conserved

among known members of the ETS family, we showed that interfacial hydration could be
modulated in a protein/DNA complex. Presumably, additional strategic point mutations could
achieve further fine-grained tuning of hydration in a strongly osmotically sensitive system such as
PU.1. However, interfacial hydration plays distinct roles in this family, as PU.1ΔN167 Y252F binds
its target DNA site just as well as wild type PU.1 under norm-osmotic conditions but affinity for
Ets-1 ΔN331Y412F is reduced. This disparity arises from DNA-bound Ets-1’s low dependence on
interfacial hydration in the first place and the coupling of a specific water-mediated contact (via
Tyr412) to induced dynamics in the DNA-bound state. The present observations add to a growing
line of evidence attesting that ETS homologues, despite their structurally superimposable DNAbound structures, recognize target DNA sites by distinct mechanisms.
2.6

Materials and methods
2.6.1

Nucleic acids

Synthetic DNA oligos were purchased from Integrated DNA Technologies (Coralville, IA)
and annealed to form duplex binding sites. DNA sites were the optimal binding sequences for PU.1
(5′-AGCGGAAGTG-3′) (197) and Ets-1 (5′GCCGGAAGTG-3′, termed SC1); (198) the ETSspeciﬁc core consensus is in bold. Fluorescent DNA probes were constructed by annealing a TYE
563-labeled oligo with excess unlabeled complementary strand as described. (184) Concentrations
of unmodiﬁed oligos were determined spectrophotometrically using nearest-neighbor extinction
coeﬃcients. (199)
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2.6.2

Molecular cloning

The cloning of the ETS domains of murine PU.1 (residues 167 to 272, designated
PU.1ΔN167) and Ets-1 (residues 331 to 440, designated Ets-1ΔN331) have been described
previously. (162,178) The point mutants Y252F for PU.1 and Y421F for Ets-1 were constructed
by standard PCR mutagenesis. Brieﬂy, for each construct separate PCR reactions were performed
using mutagenic primers to produce two DNA fragments with overlapping sequences that harbored
the intended Tyr-to-Phe mutation. A second PCR ampliﬁcation of the ﬁrst-round products with
external primers generated the ﬁnal construct that was cloned into pET28b vector and propagated
in DH5α Escherichia coli cells under kanamycin selection (50 μg/mL). Clones were veriﬁed by
Sanger sequencing and transformed into BL21*(DE3) E. coli for expression
2.6.3

Protein Expression and Puriﬁcation

Wild type or mutant ETS constructs were overexpressed in Escherichia coli as fusions with
a thrombin-cleavable C-terminal 6xHis tag and puriﬁed as previously described. (162) In brief,
cleared lysate from sonicated cell pellets were ﬁrst puriﬁed on Co-NTA by immobilized metal
aﬃnity chromatography, cleaved with thrombin, dialyzed against 10 mM NaH 2PO4/Na2HPO4 (pH
7.4) containing 0.5 M (for PU.1) or 0.15 M (for Ets-1) NaCl, and polished on Sepharose SP (GE).
Buﬀers used with Ets-1 constructs, which harbored reduced cysteine, additionally contained 0.5
mM TCEP. Puriﬁed constructs were homogeneous as judged by Coomassie-stained SDS-PAGE.
Protein concentrations were determined by UV absorption at 280 nm using the following
extinction coeﬃcients (in M−1 cm−1): 22460 (wild type PU.1ΔN167), 20970 (PU.1ΔN167Y252F),
32430 (wild type Ets-1ΔN331), and 30940 (Ets-1ΔN331Y412F).
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2.6.4

Fluorescence Polarization Titrations

ETS protein binding to ﬂuorescently labeled DNA sites was measured in a solution using
a Molecular Devices Paradigm plate reader. TYE-labeled DNA probe (0.5 nM) was incubated to
equilibrium with puriﬁed wild type (PU.1ΔN167 or Ets-1ΔN331) or mutant protein
(PU.1ΔN167Y252F or Ets-1ΔN331Y412F) and graded concentrations of unlabeled high aﬃnity
site in 30 μL of total volume. The solution was 10 mM TrisHCl (pH 7.4) containing 150 mM total
Na+, 5 mM DTT, 0.1 mg/mL acetylated bovine serum albumin (Promega), and betaine as
indicated. Solution osmolality was measured using a freezing point depression osmometer
(Osmomat 3000, GonoTec) calibrated with commercial NaCl standards. Immediately before
ﬂuorescence measurement, samples were transferred to black 384-well plates (Corning) and
excited at 535/25 nm. Steady-state ﬂuorescence parallel and perpendicular to the incident polarized
light were acquired at 595/35 nm. Dark counts of a buﬀer-only control were subtracted from each
emission count before conversion to the anisotropy using a grating factor that was independently
determined with sulforhodamine B (⟨r⟩ = 0.025 at 25 °C). Anisotropy data from multiple
experiments were ﬁtted simultaneously with a mechanistic binding model to directly estimate the
dissociation constants ± SE of each protein complex with unmodified DNA. (184)
2.6.5

Circular Dichroism Spectroscopy

Puriﬁed proteins were extensively dialyzed against 10 mM NaH 2PO4/Na2HPO4 (pH 7.4)
containing 150 mM NaCl before scanning from 300 to 190 nm at 10 μM in a 1 mm-path length
quartz cuvette at 25 °C using a Jasco J-810 instrument. Per-residue normalized spectra were
decomposed using BeStSel, (200) without scaling, to estimate their secondary structure contents.
Melting experiments were carried out with 25 μM of each construct, detected at 222 nm while

49
heated at 45 °C/h to 70 °C, followed by cooling at the same rate. Melting and refolding data were
simultaneously ﬁtted to a uni-molecular two-state transition with independent linear baselines.
2.6.6

Size Exclusion Chromatography

Puriﬁed proteins (3 nmol) were injected and eluted at 1.3 mL/min with 10 mM
NaH2PO4/Na2HPO4 (pH 7.4) containing 150 mM NaCl and 0.5 mM TCEP in a Superdex 75 10/300
GL column (GE) under the control of a Bio-Rad NGC instrument. The column was calibrated with
bovine serum albumin (66 kDa), carbonic anhydrase (30 kDa), and myoglobin (17 kDa). Eluate
was detected by UV absorption at 280 and 409 nm, the latter speciﬁc for the Soret band of
myoglobin. The void volume of the column was 8 mL.
2.6.7

2D 1H−15N HSQC NMR

Uniformly 15N-labeled wild type Ets-1ΔN331 and Ets-1ΔN331Y412F were expressed in
M9 minimal media containing

15

NH4Cl and puriﬁed identically as unlabeled proteins. Samples

(∼0.3 mM) were extensively dialyzed against 11 mM NaH2PO4/Na2HPO4, pH 7.4, 167 mM NaCl,
and 0.1% NaN3 and adjusted to 10% D2O. 1H−15N correlated measurements were made using a
phase-sensitive, double inept transfer with a garp decoupling sequence and solvent suppression
(hsqcf3gpph19). Spectra were acquired with 1k × 144 data points and zero-ﬁlled to 4k × 4k
2.6.8

Molecular Dynamics Simulations

Free and site-speciﬁcally bound wild type and mutant ETS domains of PU.1 and Ets-1 were
simulated using GROMACS 2016.1 with the CHARMM36 force ﬁeld. Starting coordinates for
the wild type ETS domains of PU.1 and Ets-1 were taken from available (co)crystal structures and
trimmed to the same length after alignment of their protein sequences. The DNA was mutated to
the experimental sequences without altering any existing backbone or sugar coordinate using
3DNA. (201) The target Tyr residues were mutated to Phe using CHARMM-GUI. (202) All crystal
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waters were retained as TIP3P waters. Each system was placed in a dodecahedral box of TIP3P
water with a minimum of 1.0 nm from its periodic boundary and neutralized with 0.15 M NaCl.
The systems were then minimized by steepest descent. The energy-minimized systems were
further relaxed, in order, as NVT and NPT ensembles for 100 ps at 2 fs time steps at 298 K with
restraints on the macromolecules. Afterward, restraints were removed from the equilibrated
systems and run for 100 ns for unbound proteins and 200 ns for DNA-bound complexes at 2 fs
time steps at 298 K. Bond constraints were introduced using the LINCS algorithm at order 4.
Coordinates, velocities, and energies were saved at 10 ps intervals. Trajectories were then imaged
and analyzed using GROMACS tools. In cases where the lengths of the bound DNA were diﬀerent,
RMS measurements were limited to corresponding protein in the structures. Hydrogen-bond
enumerations were carried out using geometric cut-oﬀs of 0.35 nm for distance and 150° for angle
(between donor-H and donor−acceptor heavy atoms).
2.7

Addendum in dissertation
As detailed in the legend to Figure 2.5C, a per-residue B-factor was computed as a measure

of the RMSF in the simulation and experimental models (1R36 and 2STT), via the relationship:

B

8 2
(RMSF)2 . Strictly speaking, NMR ensembles represent a set of structures that satisfy the
3

experimental distance and angular constraints imposed by NOE and other NMR observables. Our
interpretation of locally loose constraints in terms of dynamics, rather than an artefact of the NMR
data, is based on the quality analyses of 1R36 and 2STT curated by the RCSB. The neighborhoods
of loose constraints exhibit levels of clashes and Ramachandran/sidechain outliers consistent with
the overall (high) quality of the models. The close spatial correspondence with the unrestrained
simulations as shown in Figure 2.5C lends further credence to our interpretation.
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Figure 2-1 Highly conserved interfacial tyrosine coordinating a tripartite water-mediated
ETS/DNA contact.
(A) Sequence alignment of the 28 murine members of the ETS transcription factor family, in
which an interfacial Tyr (green ●) is conserved in 26 homologs including PU.1 (Spi1; Tyr252) and
Ets-1 (Tyr412). Residues are colored by amino acid type. Symbols denote identity (∗), strong (:),
or partial (·) conservation. (B−G) Diﬀerential interfacial hydration in the cocrystal structures of
PU.1 (PDB 1PUE) and Ets-1 (1K79). (B and C) Hydration water within 5 Å of a conserved
interfacial Arg (Arg235 in PU.1, Arg394 in Ets-1; (purple ●) in panel A) is shown as cyan spheres.
(D and E) Water-mediated contacts (within 3.4 Å) in the protein/DNA interface of PU.1 and Ets1, the latter contacting DNA primarily via direct contacts. Tyr252 and Tyr412 are marked by red
arrows. (F and G) Expanded view of Tyr252/Tyr412 coordinating a highly conserved watermediated contact with Arg235/Arg394 and a speciﬁc DNA backbone phosphate
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Figure 2-2 Mutation of an interfacial tyrosine to phenylalanine perturbing DNA-binding
aﬃnity and sensitivity to osmotic pressure by the ETS domains of PU.1 and Ets-1
(A) Electropherograms from Sanger sequencing of recombinant ETS constructs harboring the oneatom-diﬀerent Tyr-to-Phe mutations in PU.1ΔN167 and Ets-1ΔN311. (B) Representative
ﬂuorescence polarization titrations of ETS-bound, TYE-labeled DNA with unlabeled, optimal sitespeciﬁc DNA under normal-osmotic (0.29 osmolal) and osmotically stressed (2.5 osmolal)
conditions. DNA probe was present at 0.5 nM and protein between 10 to 100 nM, depending on
construct and conditions, to establish pre and post-titration baselines. Wild type and mutant protein
binding are denoted by solid and open symbols, respectively. Curves represent ﬁts of the data to a
1:1 competitive model. (C) Osmotic dependence of the binding constant shows sharply diﬀerent
responses by the two ETS homologs and their mutants to osmotic pressure. Lines represent
weighted linear ﬁts for each data set.
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Figure 2-3 Analogous Tyr-to-Phe mutations which are diﬀerentially perturbative to the
unbound PU.1 and Ets-1 ETS domains
(A) Far-UV circular dichroism scans of wild type (solid symbols) and mutant (open) PU.1ΔN167
and Ets-1ΔN331 at 25 °C, ﬁtted with BeStSel (curves) to estimate secondary structure content.
Parametric values are given in Table 1. (B) Thermal melting (up triangles) and cooling curves
(down triangles) of wild type and mutant PU.1ΔN167 and Ets-1ΔN331, monitored at 222 nm.
Neither ETS-1 construct unfolded reversibly (gray down triangles). Heating and, if reversible,
cooling data was globally ﬁtted with a uni-molecular two-state model (curves). Values are given
in Table 1. (C) Size-exclusion chromatography of puriﬁed wild type and mutant PU.1ΔN167 and
Ets-1ΔN331 on a Superdex 75 column, which was calibrated with bovine serum albumin (peaks 1
and 2; a 132 kDa dimer and 66 kDa monomer), carbonic anhydrase (peak 3, 30 kDa), and
myoglobin (peak 4, 17 kDa, detected via its Soret band at 409 nm). (D) Overlaid solution HSQC
spectra of wild type (gray) and Ets-1ΔN331Y412F (black). Where possible, chemical shift
assignments of wild type resonances that exhibited the largest chemical shift changes (partial or
complete lack of overlap) were taken from the solution NMR structure (PDB: 1R36). (188) Identity
in the case of partially overlapped mutant residues was not assumed. Asterisks denote side-chain
resonances.
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Figure 2-4 Molecular dynamics simulations recapitulate experimental properties of the
unbound ETS domains of PU.1 and Ets-1
Following all-atom simulations for 100 ns at 298 K, the trajectories and structures of the ETS
domains of PU.1 and Ets-1 were analyzed in terms of RMS deviation from initial coordinates
(RMSD, parts A and B), hydrogen bonds with solvent (parts C and D), and mean square
displacement (MSD, parts E and F). The RMSD data showed rapid convergence in the dynamics
of both sets of proteins. Enumeration of H-bond contacts with solvent showed a 4% bias in favor
of wild type Ets-1, consistent with its thermal instability relative to the Y412F mutant. Finally, the
lower MSD of wild type Ets-1 relative to PU.1 reﬂects dynamic light scattering measurements
showing a 14% larger hydrodynamic radius for ETS-1. The MSD trajectories were divergent out
to 100 ns.
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Figure 2-5 Molecular dynamics simulations recapitulating induced experimental dynamics
in the wild type Ets-1 complex and revealing a basis for destabilization by Y412F mutation
(A) All-atom RMS deviation from initial coordinates for wild type and mutant PU.1 and Ets-1 in
their DNA-bound states. (B) Per-residue RMS ﬂuctuations, computed from the ﬁnal 50 ns of the
simulations, revealed signiﬁcant dynamic bias in wild type Ets-1 (positive values indicate excess
dynamics in wild type), but not PU.1. The red line represents the average RMSF ± SE. Dynamics
of the bound DNA, not shown, exhibited identical trends. (C) Comparison with experimental NMR
structures shows that the simulations reproduced the localized dynamics in the wild type Ets1/DNA complex. Both experimental structures were averaged from 25 conformers in the PDB
ensemble; the simulated averaged structure consisted of 5000 models. Fluctuations are colored by
residue based on a “B-factor” (proportional to RMSF) on a scale from 0 to 100 in a blue-white-red
continuum, computed from the ﬂuctuations from average positions. This scaling is intended only
to facilitate a comparison of the isotropic simulated and experimental ﬂuctuations on a common
scale. Corresponding sites of induced dynamics between the simulated and experimental wild type
Ets-1/DNA complexes are marked by arrows (the DNA is rendered semitransparent for clarity).
The secondary structure assignments of the simulated structures are inherited from their
crystallographic templates and diﬀer at places from the solution NMR structure. Tyr412 (wild
type) and Phe412 (mutant) are shown in green and pink, respectively.
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Figure 2-6 Molecular dynamics simulations of DNA-bound PU.1 and Ets-1 ETS domain,
which provide a window into the interfacial hydration of wild type and mutant PU.1 and Ets-1
(A) Groups in the ETS/DNA interface are used to probe interfacial hydration. Heteroatoms used
as probes for solvent H-bonds are highlighted in red. Note that the H-bonding atoms in Group 4
(representing the 5′-GGAA-3′ core consensus) speciﬁcally face the major groove toward the
protein; backbone sugar and phosphates are schematized. (B) Solvent H-bond contacts were made
by the indicated groups given as the average of three independent simulations. The curves (dashed
and solid for wild type and mutant, respectively) represent FFT-smoothed averages based on a 2.5
ns window.
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Table 1 Conformational Properties of Free Wild type and Mutant ETS Domains of PU.1
and Ets-1a
Secondary structure content, %

a

Conformational stability

α helix

β sheet

Turns

Other

Tm, °C

ΔH(Tm) × 105,
kJ/mol

PU.1ΔN167WT
PU.1ΔN167Y252F

22.9
22.4

31.3
26.2

13.9
15.0

31.9
36.4

47.9 ± 0.2
48.2 ± 0.2

26.6 ± 1.5
29.2 ± 1.6

Ets-1ΔN331WT
Ets-1ΔN331Y412F

25.0
24.2

36.5
32.0

9.3
14.2

29.2
29.6

44.6 ± 0.1b
51.9 ± 0.2b

44.2 ± 1.4b
30.1 ± 1.4b

Secondary structure content for each construct was estimated by decomposition of their CD
spectra using the BeStSel algorithm (200). Conformational stability was measured by CD-detected
thermal denaturation and renaturation and ﬁtted globally for both heating and cooling (where
possible) by a uni-molecular two-state model. b Determined from heating curve only.
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INTRINSIC DISORDER CONTROLS TWO FUNCTIONALLY DISTINCT
DIMERS OF THE MASTER TRANSCRIPTION FACTOR PU.1

Copyright © American Association for the Advancement of Science [Science Advances Volume
6, Number 8] 21 Feb 2020 DOI: 10.1126/sciadv.aay3178
3.1

Abstract
Transcription factors comprise a major reservoir of conformational disorder in the

eukaryotic proteome. The hematopoietic master regulator PU.1 presents a well-defined model of
the most common configuration of intrinsically disordered regions (IDRs) in transcription factors.
We report that the structured DNA binding domain (DBD) of PU.1 regulates gene expression via
antagonistic dimeric states that are reciprocally controlled by cognate DNA on the one hand and
by its proximal anionic IDR on the other. The two conformers are mediated by distinct regions of
the DBD without structured contributions from the tethered IDRs. Unlike DNA-bound complexes,
the unbound dimer is markedly destabilized. Dimerization without DNA is promoted by
progressive phosphomimetic substitutions of IDR residues that are phosphorylated in immune
activation and stimulated by anionic crowding agents. These results suggest a previously
unidentified, nonstructural role for charged IDRs in conformational control by mitigating
electrostatic penalties that would mask the interactions of highly cationic DBDs.
3.2

Introduction
Eukaryotic transcription factors are highly enriched in intrinsically disordered regions

(IDR), which are sequences that do not adopt a stably structured conformation but are nevertheless
essential for activity. Compared with only ~5% in prokaryotes and archaea, more than 80% of
eukaryotic transcription factors have extended IDRs (203). In the unicellular baker’s yeast
(Saccharomyces), transcription factors comprise the most prodigious functional category of
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disorder encoding proteins (204). In multicellular organisms, ~50% of all residues in eukaryotic
factors from model animals (humans, Drosophila) and plants (Arabidopsis) map to disordered
regions (45). Clearly, IDRs constitute a major component in eukaryotic gene regulation, and it is
therefore important to define their contributions to the molecular properties of transcriptional
factors.
While IDRs are generally diverse in sequence, charge characteristics confer specific
properties to transcription factor IDRs. For example, positively charged tails mediate diffusion
along DNA (205) and ubiquitination by E3 ligases of several transcription factors, notably p53
(206). More common, however, are negatively charged (“acidic”) IDRs such as transactivation
domains, which recruit basal factors such as TFIIB and TATA binding protein to the promoter
(207,208), and signaling moieties such as PEST domains that are rich in Glu and Asp residues
(209,210). While IDRs exhibit sequence-dependent conformational preferences on their own,
these preferences are also modified by folded domains to which they are tethered (211). In
transcription factors, IDRs are highly enriched around DNA binding domains (DBDs) (212),
which display electrostatically biased surfaces to their surroundings. Their DNA contact surfaces
are typically rich in positively charged residues while exposing neutral or even negatively charged
residues elsewhere. Because DBDs alone represent an incomplete context in functional regulation,
our aim is to elaborate the mechanism by which charged, particularly acidic IDRs regulate the
recognition of tethered DBDs with each other as well as with target DNA.
As a model system for understanding the impact of intrinsically disordered tethers in
transcription factors, the ETS family protein PU.1 exemplifies the most common (known as type
I) configuration (45), in which its eponymous DBD of ~90 residues comprises the only well-folded
structure. The remaining ~170 and 12 residues that flank N- and C-terminally, respectively, are
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intrinsically disordered sequences. The extended N-terminal IDR consists of an acidic
transactivation domain (human residues 1 to 80), a Q-rich domain (residues 81 to 116), and a
highly negatively charged PEST domain (residues 117 to 165), all of which are characteristic
disordered regions in eukaryotic factors (210). This domain architecture, conserved among PU.1
orthologs, commends PU.1 as an ideal model from which more complex transcription factor
architectures may be approached.
In addition to the canonical attributes representative of eukaryotic transcription factors,
PU.1 is also specifically required for life. During hematopoiesis, all circulating blood cells are
ultimately derived from a small population of self-renewing stem cells. PU.1 is a master regulator
that is required for the renewal of the hematopoietic stem cells (213) and, in collaboration with
other factors, directs their differentiation to every major myeloid and lymphoid lineage. Aberrant
PU.1 activity is associated with lymphomas (214), myeloma (215), leukemia (216), and
Alzheimer’s disease (217). Most recently, PU.1 was also identified as the key trigger for tissue
fibrosis (156). Genetic and pharmacologic interventions targeted at PU.1 have established its
therapeutic potential in acute myeloid leukemia (157,158) and fibrotic diseases (156). Mechanisms
that govern the molecular interactions of PU.1 are therefore relevant to developmental genetics
and multiple therapeutic areas including hematology/oncology, immunology, neurology, and
rheumatology.
Despite its biological significance, detailed knowledge of the molecular properties of PU.1
has been limited to its structured ETS domain. PU.1 therefore exemplifies the “incomplete context
problem” in structural biology, which we have now tackled by addressing the role of the N- and
C-terminal IDRs in the behavior of the ETS domain. The data reveal that these tethered IDRs
critically control the propensities of the ETS domain to form discrete dimers with and without
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cognate DNA. These dimeric states, which are conformationally distinct, establish a novel
regulatory mechanism that enables negative feedback in PU.1 transactivation. In addition to
implications on PU.1 autoregulation in vivo, these results address a general class of problems in
which negatively charged IDRs, which are abundant in transcription factors as transactivation and
other functional domains, exert direct functional control at the protein/ DNA level.
3.3

Results
The DNA binding (ETS) domain of PU.1 represents its only structured domain, whose 1:1

complex with cognate DNA [Fig. 3.1A] is structurally conserved in this family of transcription
factors. However, in contrast with other ETS members, the ETS domain of PU.1 (N165) forms
2:1 complexes at single DNA cognate sites in biophysical assays (163,164). Measurements of selfdiffusion by protein-observed diffusion ordered spectroscopy (DOSY) nuclear magnetic resonance
(NMR) showed that inclusion of the N-terminal PEST domain (N117) maintained the DNA
binding modes accessible to the ETS domain [Fig. 3.1B]. Specifically, DOSY titrations of both
N117 and N165 with DNA oligomers harboring a single cognate binding site showed two
distinct bound states, with the minima in diffusion coefficient occurring sharply at a DNA: protein
ratio of 0.5, corresponding to a 2:1 complex. The single minima at DNA: protein = 0.5 excluded
the formal possibility of a 2:2 complex or nonspecific binding. If PU.1 were binding DNA
nonspecifically beyond the 1:1 complex at equilibrium (i.e., in an un-saturable manner
proportional to the concentration of free protein), then the minima in diffusion coefficient would
occur at the lowest DNA: protein ratios where protein would be at greatest excess relative to DNA.
Independently, protein-into-DNA titrations showed that N117 enhanced the affinity of the 1:1
complex (KD1) by more than twofold and reduced the affinity of the 2:1 complex (KD2) relative to
N165 by about fourfold [Fig. 3.1B]. Taking the ratio KD2/KD1 as an index of cooperativity in
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DNA binding, 2:1 complex formation by N117 was therefore more negatively cooperative than
N165. The PEST domain, therefore, preserved the intrinsic binding modes of the ETS domain of
PU.1, namely, a 1:1 and 2:1 complex with cognate DNA, while modulating their affinities in
solution.
3.3.1

PU.1 is self-regulated by negative feedback

In tissues that natively express PU.1, such as macrophages, PU.1 activity is highly
inducible (218). The 1:1 complex formed by ETS domains represents the established transregulatory complex for ETS transcription factors. Little is understood about the functional nature
of the 2:1 complex, for which no ETS analog is known, although its negative cooperative
relationship with the 1:1 complex suggests an inactive species [Fig. 3.1C]. To solve this puzzle,
we measured PU.1 transactivation in cells using an enhanced green fluorescent protein (EGFP)
reporter gene under the control of various synthetic enhancer elements consisting only of tandem
copies of the λB motif [Fig. 3.1D], a PU.1-specific ETS binding site (EBS) derived from the
lymphoid Igλ2-4 enhancer (GenBank X54550). Each consecutive site was spaced by 20 base pairs
(bp), or two helical turns, such that bound proteins were arrayed on the same helical face to
facilitate the recruitment of the transcriptional machinery. In addition, as the 2:1 complex was
known to require an extended site size relative to the monomer (164), presenting the bound protein
along one helical face would amplify site-site interactions and DNA perturbations, thus rendering
most manifest the functional effects of the 2:1 complex.
When transiently transfected into PU.1-negative human embryonic kidney (HEK) 293
cells, the reporters were negligibly activated by endogenous transcription factors, including other
ETS family proteins [Fig. 3.1E]. Co-transfection of an expression plasmid encoding full-length
PU.1, which was independently tracked by a co-translating infrared fluorescent protein (iRFP)
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marker, yielded EGFP fluorescence in a dose-dependent manner. We established a dosing range
for the PU.1 expression plasmid that gave a linear variation in PU.1 abundance in HEK293 cells
within the physiologically inducible range found in PU.1-expressing myeloid cells [Fig. 3.2]. In
this configuration, PU.1-dependent transactivation was quantified as the fraction of iRFP-positive
cells that were also EGFP positive [Fig. 3.1E]. The functional outcome of an inactive, negatively
cooperative 2:1 complex would be a bell-shaped reporter dose-response as the enhancer, which
varied in density and spacing of EBS (i.e., cis regulatory syntax), became saturated with
nonproductively (2:1) bound PU.1. In the alternative, the reporter signal would dose-dependently
settle to a saturable level, depending on the level at which the 2:1 complex retained activity relative
to the 1:1 complex. The synthetic B reporters were therefore well suited to interrogate cellular
PU.1 activity, free from the requirement or interference from other promoter-specific cofactors, at
the protein/DNA level.
At equivalent PU.1 doses, all enhancer configurations showed graded reporter expression
in step with the density of EBS at each enhancer [Fig. 3.1F]. This was consistent with an expected
multivalent effect with respect to PU.1 binding sites. However, EGFP expression increased
monotonically only with enhancers harboring tandem 3× and 5× EBS. Upon peaking at
intermediate PU.1 doses, the 1× and 2× enhancers were repressed by further increases in PU.1. To
determine whether the reversal in transactivation involved PU.1 interaction at the enhancer, we
mutated the even-numbered sites in the 5×EBS reporter to generate a 3×EBS variant in which the
cognate sites doubled in spacing [Fig. 3.1D]. The resultant 3×-alt-EBS reporter exhibited lower
transactivation than the more densely spaced 3×EBS, and its reporter signal also no longer
increased monotonically [Fig. 3.1F]. The spacing effect, therefore, demonstrated that the
functional reversal could not be due solely to PU.1 interaction away from the DNA, which would
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be inert to syntax changes at the DNA. The observation of bell-shaped dose response for the 1×
and 2× enhancers, but not the 3× or 5×EBS enhancers, suggested additive perturbations of the local
DNA structure, which were amplified by the helical spacing of the sites. This interpretation was
supported by previous DNA footprinting of the PU.1 ETS domain, which showed strong
differences between the singly and doubly PU.1-bound DNA (164). Alternatively, binding at the
higher-density sites might exhaust a required co-repressing factor for the 2:1 complex. However,
this possibility was discounted by the different dose responses exhibited by the 3×EBS and 3×-altEBS, which had the same site density, and the occurrence in a cell line (HEK293) that does not
natively use PU.1 in gene regulation. Because net transactivation activity was reduced under
conditions corresponding to population of the 2:1 complex, the evidence suggested that the 2:1
complex lost activity relative to the 1:1 complex. Thus, manipulation of enhancer syntax (density
and spacing) demonstrated negative feedback in PU.1 transactivation in a manner consistent with
self-titration of the transcriptionally active 1:1 complex by an inactive dimer bound to DNA
To extend our functional results to a more physiologic context, we evaluated the impact of
graded PU.1 inhibition on three PU.1 target genes in THP-1 cells, a widely used human
monocyte/macrophage model. Cells were treated with a PU.1 inhibitor [Fig. 3.3], as a function of
dose or incubation period, before stimulation with phorbol 12-myristate 13-acetate (PMA) to
mimic PU.1 induction during myeloid differentiation. As PU.1 targets, we examined the pu.1 (Spi1) gene itself, which is auto-regulated (219); csf1ra, a PU.1 target that encodes the  subunit of
the colony-stimulating factor receptor; and e2f1, which is negatively regulated by PU.1(220). We
first tested the effect of dose-dependent inhibition of PU.1 for a fixed period of 2 hours on the
transcription of these genes by reverse transcription polymerase chain reaction (RT-PCR) (table
S2). Expression of pu.1 and csf1ra, both positively regulated PU.1 targets, was increased by lower
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doses of inhibitor before marked reduction to ~50% at higher doses, yielding bell-shaped profiles
[Fig. 3.1G]. In the case of negatively regulated e2f1, expression was further inhibited across the
dosage range of inhibitor tested. Trans-regulation of all three genes upon dose-dependent
inhibition of PU.1 was consistent with an increase in PU.1 activity associated with the relief of
negative feedback.
To assess the impact of PU.1 inhibition temporally, we tested a fixed dose of inhibitor (20
M) over time, up to 16 hours before PMA induction. While PU.1 expression gave a bell-shaped
dose response at 2 hours of inhibitor exposure, continued exposure at an intermediate (derepressing) dose became strictly inhibitory [Fig. 3.1G]. In contrast, de-repression in csf1ra
expression continued for 8 hours. Expression of the negative-regulated e2f1 gene, which was dosedependently reduced at 2 hours of PU.1 inhibition, began to increase by 8 hours of inhibitor
exposure. These results thus demonstrated a dynamic nature to the negative feedback that
corresponded to the specific effect of PU.1 on the target gene (peaks in activated genes or troughs
in repressed genes). The opposing behavior of csf1ra and e2f1 expression, in accordance to their
opposite dependence on PU.1, supported the physiologic relevance of PU.1 negative feedback.
Last, the latency exhibited by the two target genes relative to the auto-regulated pu.1 gene
suggested a combined effect between changes in PU.1 availability at the expression level and
competition for binding at the DNA level.
In summary, the expression profiles of pu.1, csf1ra, and e2f1 showed that graded PU.1
inhibition led to non-monotonic changes in trans-regulatory activity in a manner consistent with
depression of negative feedback. Together with the dependence of the synthetic B reporter on
PU.1 dose and enhancer syntax (site density and spacing), the data support the biophysically
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observed 2:1 complex as a functionally relevant species in the cell and motivate specific interest
in how the ETS domain dimerizes in its native structural context
3.3.2

The PU.1 PEST domain is an IDR that modulates the stability of the 2:1 DNA
complex

Comparison of DNA binding by N117 and N165 shows that the N-terminally tethered
PEST domain enhanced the affinity of the 1:1 complex but reduced the affinity of the 2:1 complex
[Fig. 3.1B]. To better understand the influence of the PEST domain on DNA recognition by PU.1,
we first established whether the PEST domain was disordered in the cognate complex by
comparing the 1H-15N heteronuclear single quantum coherence spectroscopy (HSQC) fingerprint
region of DNA-bound N165 and N117 [Fig. 3.4A]. As with ΔN165 (164), the unbound and 1:1
complex gave well-dispersed spectra, while >80% of the cross peaks for 2:1-bound N117 were
broadened out [Fig. 3.5]. The similar behavior by the two constructs indicated that broadening was
not due to the larger size of the 2:1 complex, in which case broadening would be exacerbated for
N117. In 1:1-bound N165, whose resonances were well resolved, 88 of the 95 assigned residues
overlapped with N117, with all PEST residues clustered around 8.2 ± 0.2 parts per million (ppm)
on the 1 H dimension, a chemical shift characteristic of disordered structures. Because this region
also represented the residues that were detected in HSQC of the 2:1 complex [Fig. 3.5], the
evidence suggested similar changes in the chemical environment for the structured ETS domain
(represented by the dispersed resonances in intermediate exchange) between free and DNA-bound
states of N117 and N165. Thus, the local structure of the ETS domain was not altered upon
DNA binding by the flanking residues, and the PEST domain behaved as a disordered tether in the
ETS/DNA complex.
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Ligand binding to DNA is generally sensitive to electrostatic interactions. To better
understand the impact of the disordered PEST domain on 2:1 complex formation, we probed the
electrostatic contribution to site-specific binding by N165 and N117 [Fig. 3.4B]. Reducing Na+
concentration from 0.15 M (as shown in Fig. 3.1B) to 0.10 M did not affect 2:1 binding by ΔN117.
However, the biphasic binding indicative of strongly negatively cooperative formation of the 2:1
complex for N165 was abolished as the anisotropy values showed. A further reduction to 0.05 M
salt resulted in monophasic transitions to the 2:1 complex by both constructs. Notably, binding
weakened with decreasing Na+ concentration and therefore could not reflect simple electrostatic
effects on DNA binding. These observations indicated that additional unbound species must
regulate DNA recognition by PU.1 and that these species were salt sensitive and controlled by the
disordered PEST domain
3.3.3

The disordered PEST promotes PU.1 homo-dimerization

The isolated ETS domain, N165, forms a feeble dimer without DNA, as judged by
heteronuclear NMR (221) as well as static and dynamic light scattering (163). To determine the
role of the disordered PEST domain in PU.1 dimerization without DNA, we examined several
hydrodynamic parameters, which are highly sensitive to self-association, of N117 as a function
of concentration [Fig. 3.6A]. DOSY NMR spectroscopy revealed a marked concentration
dependence for the apparent diffusion coefficient. The profile was described by a two-state
monomer-dimer equilibrium (detailed in Materials and Methods) with a dissociation constant
below 10 M (table S1). To assess concentrations below 50 M, which was limiting for NMR, we
performed intrinsic Trp fluorescence anisotropy measurements, which is sensitive to rotational
diffusion. N117 exhibited a substantial change in steady-state anisotropy that was also described
by a two-state dimer with a dissociation constant at below 10 M. In contrast, N165 showed no
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change. The localization of the three Trp residues in the structured ETS domain of both constructs
represented further evidence that the concentration-dependent changes in N117 involved the ETS
domain. Last, high-precision densimetry showed a concentration-dependent transition by N117
that was again described by two-state dimerization. (Because density varies directly with
concentration, density-detected transitions sit on sloped baselines as opposed to the flat baselines
in spectrometric titrations.) Relative to the diffusion probes, the densimetric titration gave a higher
dissociation constant, 35 ± 15 M. As a control, N165 gave a concentration-independent partial
specific volume (from the slope, see Materials and Methods) of 0.77 ± 0.01 ml/g, a value
characteristic of structured globular proteins. Multiple orthogonal probes therefore described a
reversible N117 dimer that was considerably more avid than N165.
We pause to note that concentration dependence of the equilibrium constant (and melting
temperatures) rules out monomolecular interactions, such as conformational changes without
association. Local conformational changes can and do produce changes in diffusion and volumetric
parameters, but this behavior without an intermolecular component cannot depend on total
concentration at thermodynamic equilibrium. Artefacts such as aggregation during the
experiments are unlikely based on the linear post-transition baselines for all three probes (DOSY
NMR, fluorescence anisotropy, and density). Independent evaluation of purified N117 by SDS–
polyacrylamide gel electrophoresis (PAGE) and mass spectrometry (MS)

[Fig. 3.7] also

confirmed the absence of detectable contamination and aggregation. At a deeper level of analysis,
the two-state self-association model, given by Eq. 7 in Materials and Methods that fitted the
titration data in [Fig. 3.6A], is a nth-order polynomial, where n is the stoichiometry of the
oligomer. The value of n (= 2 for dimer), which is fixed in the fitting, imposes a severe constraint
on the shape of the titration to which the model may adequately fit. As detailed elsewhere (222),
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oligomers n ≥ 3 invariably show sigmoidal (S-shaped) transitions. Only a two-state dimer exhibits
non-sigmoidal profiles on linear concentration scales, precisely as constructed in [Fig. 3.6A] and
observed in the data. On this basis, the biophysical evidence is unambiguous in showing homodimerization of PU.1 without DNA, and the range of dissociation constants yielded by the different
probes reflected the distinct molecular properties they sampled.
To further strengthen this evidence, we resolved N117 by electrospray ionization (ESI)–
MS up to a concentration of 840 M. Using an established maximum entropy procedure (223),
peaks corresponding to both monomeric and dimeric PU.1 were observed in de-convoluted zerocharge mass spectra [Fig. 3.6B]. The integrated intensities of the two species were quantitative,
but they did not correspond to solution conditions in the other experiments. This was due to the
technique’s requirement for a volatile buffer (NH4HCO3), species-dependent ionization efficiency,
and the potential for ionization-induced dissociation of the complex. Notwithstanding, the ratio of
dimer-to-monomer intensities varied in favor of the dimeric species with increasing total protein
concentration [Fig. 3.6B, bottom]. The concentration dependence excluded the possibility that
either species could represent a static contaminant but rather corresponded to a N117 monomer
and dimer at dynamic equilibrium.
To gain insight into the conformational structure of the free PU.1 dimer, we interrogated
N165 and N117 by circular dichroism (CD) and NMR spectroscopy. At an identically low
concentration (25 M), a net contribution of coil content due to the PEST domain was apparent
[Fig. 3.6C]. With increasing concentration, N165 showed a spectral shift but without an endpoint
at 300 M. In contrast, the corresponding spectra for N117 (weighted by contributions from the
disordered PEST domain) underwent a non-sigmoidal transition that, unlike N165, was
substantially completed at 300 M [Fig. 3.6D]. Model fitting of the far–ultraviolet (UV) CD
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spectra, which are sensitive to secondary structure content, to a two-state dimer yielded a
dissociation constant of K2 = 46 ± 19 M. As an analysis of full CD spectra by singular value
decomposition rendered more structural information than the other titration probes in Fig. 3A, we
will use the CD-fitted K2 for comparison with other PU.1 constructs and solution conditions. To
probe the local structure of the PU.1 dimer, we compared the 1H-15N HSQC fingerprint of 400 M
N117 and N165, concentrations at which the preceding experiments showed that N117 was
predominantly dimeric, while N165 remained monomeric [Fig. 3.6E; compare to Fig. 3.6A].
Dispersed cross-peaks for the two constructs mostly overlapped within experimental uncertainty
(inset). PEST domain residues were clustered at 8.2 ± 0.2 ppm. 1H-15N-NOE (nuclear Overhauser
effect) measurements confirmed that the ETS residues in N117 remained well ordered
throughout, similarly as N165, while PEST residues exhibited much lower values as a group
[Fig. 3.6E, inset]. Thus, the N117 dimer was a fuzzy complex in which the PEST domain did not
deviate from a tethered IDR to the structured ETS domain.
3.3.4

Dimeric forms of PU.1 with and without DNA are nonequivalent

The 2:1 complex formed by PU.1 at a single cognate site suggested that the PU.1 dimer
was asymmetric, as a symmetric dimer that exposes the DNA contact surfaces would logically
yield a 2:2 complex. However, this stoichiometry was excluded by the DOSY titration data, which
showed two inflections with the least diffusive species at a DNA: protein ratio of 1:2,
corresponding to the 2:1 complex [Fig. 3.1B]. Unbound PU.1 also formed a homodimer, which
could logically arise only if the complex was symmetric. Experimentally, a symmetric dimer was
strongly inferred by a single set of 1H-15N signals for unbound N117 at high concentrations
[Fig. 3.6E]. Moreover, the CD-detected structure of PU.1 showed negligible changes upon titration
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by DNA [Fig. 3.8A], in contrast with the self-titration in the absence of DNA [Fig. 3.6D]. These
clues suggested that DNA-bound and free PU.1 dimerized into distinct conformers.
To test these notions, we constructed a constitutive ETS dimer via insertion of a single Cys
residue into N165, which did not harbor this amino acid, between residues 194 and 195
[Fig. 3.8B]. We targeted this position given its turn conformation in the known structures of the
ETS monomer [Protein Data Bank (PDB): 5W3G] and the 1:1 complex (1PUE), and its reported
involvement in 2:1 complex formation by heteronuclear NMR (164). Purification of this mutant,
termed DKCDK, by ion exchange chromatography under non-reducing conditions eluted
monomer and its cysteine-linked dimer at >1 M NaCl [Fig. 3.8C]. Fractions containing
predominantly monomer or dimer were separately dialyzed into a buffer containing 0.15 M NaCl
with or without 5 mM dithiothreitol (DTT), respectively. In the absence of DNA, the far-CD
spectrum of the DKCDK monomer (maintained with 5 mM DTT) overlapped closely with the
spectrum of N165 [Fig. 3.8D] and formed the 1:1 complex with cognate DNA similarly as wildtype N165, indicating that the Cys insertion was non-perturbative in the DKCDK monomer
[Fig. 3.8E]. In stark contrast, the cysteine-linked DKCDK dimer exhibited a CD spectrum that was
altogether unlike PU.1 at equivalent molar concentrations (400 M). It bore some similarity to a
spectrum for N165 at the highest concentration available (800 M), which contained a greater
fraction of dimeric PU.1 (dashed spectrum in Fig. 3.8D). However, the dimeric DKCDK spectrum
was further redshifted by ~7 nm and ~15% more intense. Moreover, the DKCDK dimer bound
cognate DNA >100-fold more poorly than wild-type N165 [Fig. 3.8E]. Thus, the DKCDK
mutant showed that a symmetric configuration was severely perturbed in conformation without
DNA and unlike DNA-bound wild-type N165 [compare to Fig. 3.8A]. Together with a deficiency
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in DNA binding, the DKCDK mutant demonstrated that the wild-type DNA-bound dimer was not
a symmetric species in contrast with the unbound PU.1 dimer.
To assess the feasibility of an alternative, asymmetric configuration in forming the 2:1
complex, which would involve the DNA contact surface, we then examined an R230A/R233A
mutant in the DNA-recognition helix H3 of PU.1 [Fig. 3.8B]. The double R→A mutant retained
an indistinguishable CD spectrum as wild-type N165 [Fig. 3.8F]. At a sub-saturating
concentration of wild-type N165, the addition of the mutant at a concentration that showed no
DNA binding on its own nevertheless produced strong DNA loading [Fig. 3.8G]. Such a result
would most simply arise if the R→A mutant associated with the wild-type 1:1 complex to drive
the 2:1 hetero-complex. The data thus pointed to an asymmetric PU.1 dimer in the 2:1 complex,
in which the secondary structure content of PU.1 did not change significantly. Both features
contrast sharply with the symmetric conformation required by the DNA-free dimer.
A synthesis of the evidence leads us to propose a model for PU.1 dimerization in the
presence and absence of DNA [Fig. 3.8H]. In terms of affinity, the 1:1 active complex is strongly
favored (>102 -fold) over either the 2:1 complex or the unbound dimer. Excess PU.1 drives one
or the other dimeric state depending on the presence of DNA. The key cornerstone of this model
is the nonequivalence of the two dimeric states. Specifically, the incompatibility of the free dimer
with DNA binding means that a preexisting dimer cannot serve as an intermediate for the 2:1
complex. Thermodynamic insulation of the two dimeric species leads to a mutually antagonistic
relationship, in which the formation of one species is favored at the expense of the other. N117
illustrates this antagonism, as relative to N165, the N-terminal PEST domain promotes
dimerization without DNA and reduces the affinity of 2:1 complex formation [Fig. 3.1B]. Together
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with enhancing the apparent affinity for 1:1 binding, the result is a widened concentration window
for the 1:1 complex for N117.
3.3.5

The electrostatic basis of PU.1 dimerization

The ETS domain as embodied by N165 is highly enriched in Lys and Arg residues, with
an isoelectric point (pI) of 10.5. Dimerization should, therefore, be highly sensitive to salt
concentration. Contrary to the expectation that the dimer would be stabilized at high salt, which
would screen electrostatic repulsion, the opposite was observed. CD-detected self-titration of
N165 at 50 mM Na+ showed a nearly complete two-state transition [Fig. 3.9A] but not at 150
mM Na+ [compare to Fig. 3.6A]. The low-salt spectra, extended in wavelength to 190 nm and
protein concentration to 800 M because of the reduced Cl− level, showed the same transition
characteristics as acquired at 150 mM Na+ [Fig. 3.10], indicating that the same transition was
inspected at both salt concentrations. Although the transition at 50 mM Na + corresponded to a
dissociation constant of ~200 M, it was still fivefold higher than that for N117 in 150 mM Na+
[Fig. 3.9B]. The data, therefore, reaffirmed the stimulatory role of the disordered PEST domain in
dimerization of the ETS domain while revealing an electrostatic basis in the unbound PU.1 dimer.
The sensitivity of the ETS dimer to salt allowed us to access the local structural changes in
the DNA-free ETS dimer by NMR spectroscopy. 1H-15N HSQC spectra of ΔN165 with 0.5 to
0.025 M NaCl [Fig. 3.9C] revealed a panel of residues with significant chemical shift perturbations
(CSPs). Taking the spectrum acquired in 0.5 M NaCl as the reference for monomeric PU.1, the
CSPs exhibited a well-ordered salt dependence [Fig. 3.9C, inset]. The salt-induced CSPs were
plotted as a function of residues [Fig. 3.9D], and a cutoff of 0.05 was applied to identify the
residues most affected by electrostatic interactions. These perturbed residues were spatially
diffuse, as a formal mapping to the unbound PU.1 structure demonstrated [Fig. 3.9E] and did not
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overlap with the known residues involved in 2:1 complex formation (164) We also examined the
transverse spin relaxation (T2) properties of the methyl proton peaks in the 1H spectra as a global
representation of the tumbling of N165 at different NaCl concentrations [Fig. 3.11]. The effective
T2* relaxation values for the three characteristic methyl 1H peaks at 0.025 M NaCl were up to
~25% lower than at 0.5 M NaCl and well beyond experimental error. This result indicated that the
salt-induced CSPs reflected the formation of a slower tumbling dimer.
To correlate the NMR data with the CD-detected changes, we used the heteronuclear
chemical shifts to infer secondary structure via the chemical shift index (CSI) (224). The CSI
results corroborated the CD-detected loss of -helical and gain in /coil content and furthermore
localized these changes to helix 1 (H1) and the loop between  sheet 3 (S3) and  sheet 4 (S4)
(Fig. 5F). Local H1 unwinding accounted for the CSPs observed near the N terminus of N165,
including the particularly strong CSP at Y173, while the loop between S3 and S4 gained β-sheet
structure.
3.3.6

Dimeric PU.1 is conformationally destabilized relative to the constituent
monomer

The N-terminal IDR promotes a structurally perturbative PU.1 dimer in the absence of
DNA. To reveal the underlying conformational thermodynamics of the PU.1 dimer, we performed
thermal melting experiments over a range of protein concentrations, using the near-UV CD
spectrum from 250 to 300 nm as a probe. The thermal transition was analyzed from a singular
value decomposition of the full spectra at each concentration and fitted to a two-state model. The
apparent melting temperature (Tm) dropped with increasing concentration in step with the
propensity for dimer formation [Fig. 3.9G]. N117 suffered a larger drop than N165 over a ~10fold increase in concentration. A reduction in salt concentration, which drove dimerization,
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similarly caused a larger drop in Tm for N165 (0.15 versus 0.05 M Na+; [Fig. 3.9G], dashed line).
The presentation of [Fig. 3.9G] as Tm−1 versus the logarithm of concentration implies that steeper
slopes correspond to lower enthalpies (heats) of dissociation/unfolding, which relate to the quality
of conformational interactions. To rigorously define the conformational thermodynamics of the
PU.1 dimer, we performed differential scanning calorimetry (DSC) experiments on N165 under
conditions (salt and protein concentrations) where the quantitatively major population was either
monomer or dimer [Fig. 3.9H, all values on a per-mole monomer basis]. The thermograms showed
a much greater calorimetric molar enthalpy (area under the curve) for the monomer (300 µM at
0.15 M Na+) than dimer (500 µM at 0.05 M Na+). In addition to enthalpy, DSC yields heat capacity
changes (Cp, difference in the pre- and post-transition baselines) that inform on changes in wateraccessible surface area. The N165 monomer exhibited a Cp of 3.1 ± 0.3 kJ/(mol K), in good
agreement with the structure-based value of 3.3 kJ/(mol K) from the NMR structure of the PU.1
monomer (225). In contrast, the N165 dimer exhibited a significantly reduced Cp of 0.97 ± 0.27
kJ/ (mol K). Assuming identical thermally unfolded states, the differences in heat capacity changes
indicated that N165 was less well folded than the monomer.
To probe the effect of the N-terminal IDR on the conformational stability of the PU.1 ETS
domain, we performed chemical denaturation experiments with urea, which could be reported by
intrinsic tryptophan fluorescence at much lower protein concentrations than DSC. At a strictly
monomeric concentration (1 µM) at 0.15 M Na+, N117 was only slightly more sensitive to urea,
as judged by the urea concentration at 50% unfolding, than N165 [Fig. 3.9I]. At 100 M
concentration, at which N117 is mostly dimeric but N165 remains monomeric, N117 became
significantly more sensitive to urea, suggesting highly perturbative interactions between the PEST
and ETS domains. A conformationally perturbed N117 dimer was also implied by its volumetric
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properties. The post-transition density slope in [Fig. 3.6A] yields a partial specific volume of
N117 of 0.85 ± 0.01 ml/g, which is atypically high for structured globular proteins and suggests
altered molecular packing and hydration properties. N165 was more stable at 1 µM at 0.05 M
Na+ than at 0.15 M Na+, an observation consistent with the ~2°C higher apparent Tm for 10 M
N165 over the same Na+ concentrations [Fig. 3.9G]. The N165 monomer and dimer were
therefore opposite in their conformational stabilities with respect to salt, underlining the structure
perturbation by salt or the anionic PEST domain.
In summary, spectroscopic and calorimetric measurements showed that the PU.1 ETS
dimer was destabilized with respect to unfolding relative to its monomeric constituents. Structural
considerations aside, conformational destabilization contributes to the DNA binding deficiency of
the apo ETS dimer. A destabilized dimeric state implied favorable concentration-dependent
interactions within the unfolded ensemble over the folded state. The ability of the anionic PEST
domain to promote formation of the unbound dimer in N117 therefore further suggests a basis in
mitigating the electrostatic repulsion among the cationic ETS domains.
3.3.7

The C-terminal IDR is required for PU.1 dimerization without DNA

In addition to the N-terminal IDR, the structured ETS domain of PU.1 is also tethered at
the C terminus to a shorter, 12-residue disordered segment (residues 259 to 270), as apparent in
the unbound PU.1 monomer structure [Fig. 3.12A] (225). Far-UV CD spectra at 0.15 M Na +
showed that hPU.1(117-258) and hPU.1(165-258), termed sN117 and sN165, respectively [Fig.
3.12B], lacked the secondary structure changes characteristic of N117 and 165 across
comparable concentrations [Fig. 3.12C; compare to Fig. 3.6D]. sN117 was also much less
sensitive to urea over the same protein concentration range as N117, and sN165 showed no
change relative to N165. In contrast to their dimeric deficiency without DNA, sN117 and
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sN165 were both intact with respect to dimerization with cognate DNA [Fig. 3.12D]. While
sN117 formed 1:1 and 2:1 DNA complexes with the same affinities as N117 in 0.15 M NaCl
within experimental error, sN165 was a significantly poorer DNA binder than N165 [Table 3].
In particular, 2:1 complex formation was less negatively cooperative for sN165, with the
concentration window (KD2/KD1) for the 1:1 complex only ~65% that for N165 [Fig. 3.12D].
Last, unlike ΔN165 at 0.05 M Na+, sN165 showed a negligible propensity to dimerize and
exhibited biphasic binding with cognate DNA [Fig. 3.12E; compare to Fig. 3.4B]. The divergent
impact of removing the C-terminal IDR on dimerization with and without DNA stood in clear
agreement with our concept of nonequivalent dimeric states for PU.1 and the structural
distinctiveness of the two states.
3.3.8

Phosphomimetic substitutions of the N-terminal IDR reinforce the dimeric
propensity of the DNA-free PU.1 dimer

Characteristic of many IDRs flanking DBDs, the N-terminal PEST domain in PU.1 is
highly enriched in Glu and Asp residues (pI 3.5), in sharp contrast with the positively charged
DBD (pI 10.5) to which it is tethered. The foregoing structural and thermodynamic evidence
strongly suggests that the acidic IDR interacts with the ETS domain and shifts it toward dimer
formation. Functional studies have established a panel of Ser residues in the PEST domain,
including residues 130, 131, 140, and 146 (human numbering), which are multiply phosphorylated
in cells (226,227). Phosphoserines at these positions would enhance the anionic charge density by
a substantial amount from −11 (3 Asp + 8 Glu) to −17 (~−1.5 per phosphoserine). Because these
residues are disordered, we made phosphomimetic substitutions of these residues to Asp,
generating a di-substituted (140 and 146, termed D2N117) and tetra-substituted mutant (termed
D4N117), to probe their general charge-dependent effects [Fig. 3.13A]. Far-UV CD spectra
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showed that the phosphomimetic substitutions progressively drove the affinity of the DNA-free
dimer, and the resultant dimers appeared to harbor greater random coil content than their wild-type
counterpart [Fig. 3.13B; compare to Fig. 3.6D]. In DNA binding experiments, the di-substituted
mutant D2N117 behaved approximately as wild-type N117, while the affinity of the 2:1
complex for the tetra-substituted mutant D4N117 was ~15-fold lower than that for wild-type
N117 [Table 3]. Stimulation of the unbound dimer was therefore associated with a marked
reduction in the affinity of the 2:1 complex by D4N117 [Fig. 3.13C]. As a result, the selective
effect on the 2:1 complex in D4N117 resulted in greater negative cooperativity (i.e., increasing
KD2/KD1) in the dimerization of DNA-bound PU.1. In turn, the concentration window for the 1:1
complex widened more than fourfold for D4N117 relative to wild-type N117.
The reinforcing effects of multiple phosphomimetic substitutions in the disordered PEST
domain strongly suggest that it influences the behavior of the ordered ETS domain via a generally
electrostatic, non-structurally specific mechanism. To further establish this notion, specifically the
absence of dependence on structurally specific interactions, we tested the effect of crowding
concentrations (in the range of 102 g/liter) of ovalbumin or bovine serum albumin (BSA) on DNA
binding by N165 [Fig. 3.13D]. These two anionic proteins share pIs (pI = 5.2 and 4.7 for albumin
and BSA, respectively) that are close to the PEST domain (pI = 3.5) but present well-formed
globular structures. If PEST/ETS interactions involved structurally specific interactions between
the two domains, the anionic crowders should differ significantly from the PEST domain in their
effects on DNA recognition by the ETS domain. DNA binding in the presence of up to 20% (w/v)
ovalbumin showed little effect on the 1:1 complex [Fig. 3.13D, inset] while progressively
decreasing the affinity of 2:1 binding. This behavior mirrored closely the phosphomimetic
mutants, and similarly, the more pronounced biphasic appearance in the presence of ovalbumin
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was a result of the increased negative cooperativity and widening concentration window for the
1:1 complex. With BSA, an even more anionic crowder, the effect was correspondingly more
pronounced. A concentration of 5% suppressed 2:1 binding at 10 −5 M, an almost 105-fold molar
excess of ΔN165 over DNA. Only the 1:1 complex was formed (inset). In contrast, the neutral
crowder PEG 8K preserved biphasic DNA binding [Fig. 3.14A], showing that the effects of BSA
and ovalbumin were not due to volume exclusion from crowding alone and highlighting the
importance of charge. To test our model’s prediction that BSA would, therefore, promote the PU.1
dimer, we evaluated N165 labeled with 5-fluoroTrp by 19F NMR in the presence of BSA. The
three tryptophan residues in N165 underwent distinct CSPs with 5% BSA under conditions that
gave monomers in dilute solution [Fig. 3.14B]. These changes reflected conformational
perturbations consistent with unbound dimer formation. Thus, phosphomimetic substitutions and
acidic crowding supported non-microstructural electrostatic field interactions on the ETS domain
as the basis of the PEST-stimulated dimerization in the absence of DNA.
3.4

Discussion
PU.1 is a markedly inducible transcription factor during hematopoiesis and immune

stimulation (218). Open-source repositories such as the Human Protein Atlas show that the
expression of PU.1 varies among a panel of resting cell lines by ~25-fold. Independently, singlecell cytometry shows that the abundance of PU.1 transcript in unstimulated murine bone marrow
cells ranges from less to 5% to ~50% that of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (228), a housekeeping glycolytic enzyme that is present at ~70 M in the cell (229).
Induction by ligands such as retinoic acid (230) or bacterial endotoxins (231) increases PU.1
expression another 10-fold or more. Depending on the combination of cell line, physiology, and
the presence of stimulatory ligands, cellular PU.1 abundance varies by a multiplier comparable to
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the ratio of the two dissociation constants KD2/KD1 (102 - to 103 -fold) of the 1:1 and 2:1
PU.1/DNA complexes.
In patients and animal models, PU.1 dosage is well established as critical to hematopoietic
physiology and dysfunction in vivo (216,232). Dosage effects have been extensively defined in
terms of expression, but relatively little is understood about direct dosage effects on transactivation
at the protein/DNA level. In this study, manipulation of enhancer syntax in HEK293 cells, which
do not use PU.1, demonstrated negative feedback in ectopic PU.1 trans-regulation, independent of
modifying interactions with tissue-specific coactivators. The recapitulation of negative feedback,
manifested by dose-dependent de-repression of endogenous PU.1 in myeloid THP-1 cells, strongly
supports functional relevance in native PU.1-dependent gene regulation. Characterization of the
attributable species, a 2:1 DNA complex, revealed two nonequivalent dimeric states that are
reciprocally controlled by DNA and the IDRs tethered to the structured DBD. Under physiologic
salt conditions, structural alterations that bias unbound PU.1 toward dimerization (e.g., full
phosphomimetic substitutions of the N-terminal IDR) oppose dimerization of DNA-bound PU.1.
Conversely, alterations that abrogate PU.1 dimerization (e.g., truncation of the C-terminal IDR)
promote the formation of the 2:1 DNA complex. Only at low salt conditions (e.g., 50 mM Na +) are
the DNA-free and DNA-bound dimers both favored, and the 1:1 complex is not populated. The
tethered IDRs do not appear to become part of the structured dimer but determine preference
between the two dimeric states such that the DNA-free dimer remains essentially cryptic without
both terminal IDRs.
If the 2:1 complex represents the structural basis of negative feedback, what functional
role does the unbound PU.1 dimer play? The thermodynamic relationships among the various
states accessible to PU.1 [Fig. 3.8H], critically the nonequivalent free and DNA-bound dimer,
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suggest a novel “push-pull” mechanism of PU.1 autoregulation by distinct pools of dimeric
protein. By antagonizing the 2:1 complex, we postulate that the unbound dimer suppresses
negative feedback and dynamically increases the circulating dose of transcriptionally active PU.1.
This model affords for the first time a unifying basis for the PU.1-activating effects of PEST
phosphorylation by casein kinase II and protein kinase C (227,233,234), as well as the PU.1inactivating effects of phosphorylation inhibition by oncogenic transcription factors (235), by
biasing PU.1 conformations toward or away from the unbound dimer.
Earlier in vitro studies reporting on dimers of the ETS domain (163,164,221), including
our own, did not appreciate their functional significance. The solution NMR structure of the
unbound monomer (5W3G) reflects the incomplete context afforded by the ETS domain alone
(i.e., ΔN165) at physiologic ionic strength (0.15 M Na+/K+). The dissociation constant for the PU.1
dimer in dilute solution (10−5 M) should not be misinterpreted as denoting a physiologically
irrelevant interaction. The complex formed by PU.1 and its partner GATA-1 is functionally critical
in cell lineage specification during myeloid differentiation in vivo (236), but its equilibrium
dissociation constant in dilute solution was 10 −4 M as determined by NMR spectroscopy (237).
This and other examples show how volume exclusion and other crowding effects favor interactions
in vivo relative to dilute solution. Facilitated diffusion along genomic DNA is also expected to
promote cognate occupancy beyond the affinity for oligomeric targets from free solution.
As the tethered IDRs remain disordered in fuzzy PU.1 dimers with and without DNA, their
formation is therefore unrelated to paradigms such as induced fit, conformational selection, or flycasting mechanisms that involve order-disorder transitions by the IDRs (238,239). Instead, the
charged intrinsic disorder in PU.1 is involved in through space electrostatic interactions. In the
absence of the N-terminal IDR, dimerization of the highly cationic ETS domain (N165) is
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favored by low salt. Conformational destabilization of the resultant dimer under these conditions
suggests an electrostatic penalty arising from charge-charge repulsion of the DBDs. The
stimulatory effect of the negatively charged IDR on the DNA-free dimer, therefore, arises from
attenuation of this repulsive penalty of association. A non-structurally specific basis is borne out
by the similarly favorable effects of reinforcing negative charges via phosphomimetic substitutions
in N117 as anionic crowders on N165. As phosphoserines confer higher charge density (~−1.5)
than carboxylates, phosphorylation is expected to exert an even greater effect than the
phosphomimetic substitutions. Notably, despite its nominal designation as a proteasome-recruiting
signal, the PEST domain does not target PU.1 for metabolic turnover, but it is associated with a
local role in dimerization and protein-protein partnerships such as with the lymphoid-specific
factor IRF4 (240).
The properties of the flanking IDRs on DNA binding as revealed in this study highlight the
divergent roles played by intrinsic disorder within the ETS transcription factor family, which is
united by eponymous, their structurally homologous DBDs. Many ETS members are controlled
by auto-inhibition, a mechanism that specifically involves short flanking helices in the unbound
state that unfolds and disrupts DNA binding allosterically or at the DNA contact interface (241).
High-affinity binding to native promoters requires coactivators or homo-dimerization at tandem
sites to displace auto-inhibitory helices, forming with positive cooperativity 2:2 complexes (242).
The regulatory strategy is activation through recruitment by other coactivators. In Ets-1, the
paradigm auto-inhibited ETS member, disordered elements in the serine-rich region (SRR) domain
upstream of the auto-inhibitory helices further modulate the regulatory potency of the autoinhibitory helices. Progressive phosphorylation of the SRR domain reinforces auto-inhibition
(240). PU.1, and likely its proximal ETS relatives, upends this paradigm. Lacking auto-inhibitory
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domains, high-affinity DNA binding is the default behavior. The disordered elements flanking its
structured ETS domain regulate DNA binding by modifying negative feedback. PU.1 is the
recruiter in protein-protein partnerships such as IRF4 (63). Phosphorylation of the disordered
PEST domain promotes the persistence of the active 1:1 complex and has been established as
broadly stimulatory (226,227,233,235). These contrasting features help frame in molecular and
functional terms the evolutionary divergence in the ETS family, one of the most ancient families
of transcription regulators in metazoan evolution.
As a final remark, both dimeric forms of PU.1 represent highly novel structures.
Asymmetric DNA-bound dimers are known in the case of the zinc finger protein HAP1 (243).
Zinc fingers are obligate dimers with a 2:2 subunit-to-DNA sub-site configuration. Asymmetry in
the HAP1 dimer is directed by the polarity of the DNA sub-sites bound to the subunits. The
asymmetric 2:1 complex with PU.1 involves only a single DNA site without significant change in
conformation. Functional deficiency of the 2:1 complex as evidenced by the cellular experiments
in Fig. 1, therefore, suggests perturbation of DNA structure relative to the singly bound state or
denial of specific surfaces of the 1:1 complex to form the transcriptional machinery. In contrast
with the localized surface implicated in the 2:1 complex, NMR evidence shows that the residues
involved are diffusely distributed with many buried in the PU.1 monomer, leading to a
conformationally destabilized dimer. The CSPs observed in the DNA-free dimer, namely, H1 and
the wing (S3/S4), were also recently observed for the interaction of PU.1 with a disordered peptide
from the SRR domain of Ets-1 (225). These regions may, therefore, represent interaction hotspots
for protein/protein partnerships for PU.1 in the absence of DNA. Beyond the minimal ETS domain,
the short C-terminal IDR acts in concert with the PEST domain to reinforce the dimerizing
properties of the ETS domain. Structurally, this suggests that the two IDRs likely interact
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physically, either antagonistically in the monomeric state or cooperatively in the dimeric state. In
the cytoplasm, the ETS domain mediates nuclear import of PU.1 (244), so dimerization may also
help regulate subcellular trafficking. Further studies to solve the structures of dimeric PU.1 and
map their distributions in subcellular compartments will define their dynamics in vivo and
contributions to target gene expression.
3.5

Methods and materials
3.5.1

Molecular cloning

DNA encoding fragments of human PU.1 encompassing the ETS domain with and without
various segments of its N- and C-terminal IDRs were synthesized by Integrated DNA
Technologies (IDT) (Midland, IA) and sub-cloned into the NcoI/HindIII sites of pET28b
(Novagen). For truncated constructs harboring the PEST domain (i.e., N117, sN117, D2N117,
and D4N117), Cys118 was mutated to Ser to facilitate purification and biophysical experiments.
Full-length PU.1 used in cell-based experiments was fully wild type. Various PU.1- sensitive
enhancer sequences as described in the text were also purchased from IDT and inserted between
the AgeI/BglII sites of pD2EGFP (Clontech, CA). All constructs were verified by Sanger
sequencing.
3.5.2

Cell culture

THP-1 and HEK293 cells were purchased from the American Type Culture Collection and
were routinely cultured in RPMI 1640 and Dulbecco’s modified Eagle’s medium, respectively,
supplemented with 10% heat-inactivated fetal bovine serum. Where indicated, cells were induced
with a single dose of PMA at 16 nM for 72 hours (final dimethyl sulfoxide concentration: 0.1%,
v/v). All cell lines were maintained at 37°C under 5% CO 2.
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3.5.3

Cellular reporter assays

Cellular PU.1 transactivation was measured using a PU.1-dependent EGFP reporter
construct under the control of a minimal enhancer harboring only cognate binding sites for PU.1.
In PU.1-negative HEK293 cells, the reporter was transactivated in the presence of an expression
plasmid encoding wild-type full-length PU.1 and a co-translating iRFP marker (157). Cells
(7 × 104) were seeded in 24- well plates and co-transfected with a cocktail consisting of the EGFP
reporter plasmid (250 ng) and up to 25 ng of expression plasmids for full-length PU.1, using
jetPRIME reagent (Polyplus, Illkirch, France) according to the manufacturer’s instructions. The
total amount of plasmid was made up to 500 ng with empty pcDNA3.1(+) vector. Twenty-four
hours after transfection, cells were trypsinized and analyzed by flow cytometry using an FCS
Fortessa instrument (BD Biosciences). Live cells were gated for iRFP and EGFP fluorescence
using reporter and full-length PU.1 only controls, respectively, in FlowJo (BD Biosciences) before
computing the total fluorescence of the dually fluorescent population.
3.5.4

RT-PCR experiments

Following extraction of total RNA using a spin column kit (Omega) and RT (Thermo
Fisher Scientific), RT-PCR reactions were performed on a QuantStudio 3 instrument (Applied
Biosystems) with SYBR Green PCR Master Mix (Thermo Fisher Scientific). Expression levels of
genes were normalized to gapdh. The primer sequences used for pu.1, csf1ra, e2f1, and gapdh are
given in table 2.
3.5.5

Protein expression and purification

Heterologous overexpression in BL21(DE3)pLysS Escherichia coli was performed as
previously described (164). In brief, expression cultures in LB or M9 media (the latter containing
15

NH4HCl or U-13C6-glucose as required) were induced at an optical density (OD600) of 0.6 with
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0.5 mM isopropyl β-d-1-thiogalactopyranoside for 4 hours at 25°C. Uniformly 15N- and 15N/13Clabeled constructs were expressed in appropriate M9-based media. Harvested cells were lysed in
10 mM NaH2PO4/Na2HPO4 (pH 7.4) containing 0.5 M NaCl by sonication. After centrifugation,
cleared lysate was loaded directly onto a HiTrap Sepharose SP column (GE) in 10 mM NaH 2PO4/
Na2HPO4 (pH 7.4) containing 0.5 M NaCl. After extensive washing in this buffer, the protein was
eluted in a gradient at ~1 M NaCl in phosphate buffer. Purified protein was dialyzed extensively
into various buffers, as described in the text, and diluted as needed with dialysate. Protein
concentrations were determined by UV absorption at 280 nm.
3.5.6

DNA binding experiments

DNA binding by protein was measured by steady-state fluorescence polarization of a Cy3labeled DNA probe encoding the optimal PU.1 binding sequence 5’-AGCGGAAGTG-3’. In brief,
0.5 nM of DNA probe was titrated with protein in a 10 mM TrisHCl buffer (pH 7.4) containing
0.1% w/v BSA and NaCl at concentrations as stated in the text. Steady-state anisotropies r were
measured at 595 nm in 384-well black plates (Corning) in a Molecular Dynamics Paradigm plate
reader with 530 nm excitation. The signal represented the fractional bound DNA probe ( Fb ), scaled
by the limiting anisotropies of the i-th bound ri and unbound states r0 as follows:

n
 n

r  Fb   ri  r0   r0  Fb  ri  r0
i 1
 i 1


(1)

where Fb as a function of total protein concentration was fitted to various models as
follows. In all cases, the independent variable was the total titrant concentration as taken.
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For DNA binding, the two stepwise dissociation constants describing the formation of the
1:1 and 2:1 PU.1/DNA complexes are:

[P][D]
[PD]
[PD][P]

 ω K D1
[P2 D]

K D1 
K D2

(2)

where P and D denote PU.1 and DNA. In this analysis, the binding affinities were not
further constrained by interactions of the unbound states. The ratio of KD2 / KD1  ω defines the
nature of the cooperativity of the 2:1 complex in the paradigm of McGhee and von Hippel. Values
of ω below, equal to, or above unity denote the positively cooperative, non-cooperative, and
negatively cooperative formation of the 2:1 complex concerning the 1:1 complex, respectively.
In direct titrations of the DNA probe by PU.1, the observed anisotropy change represented
the summed contributions of the two complexes as expressed by Eq (1). The most efficient
approach is to determine binding in terms of the unbound protein, P. The solution, which is cubic
in [P], is:

0  φ 0  φ1[P]  φ 2 [P]2  φ3 [P]3
φ 0  K D1 K D2 [P]t
φ  K K  K [P]  K [D]
 1
D1 D2
D2
t
D2
t

φ 2  K D2  [P]t  2[D]t
φ3  1

(3)
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where the subscript “t” represents the total concentration of the referred species. [P] was
solved numerically from Eq. (3), rather than analytically via the cubic formula, to avoid failure
due to loss of significance. With [P] in hand, [D], [PD], and [P2D] were computed from Eq. (2)
and the corresponding equations of state. In the limit of no formation of the 2:1 complex (i.e., KD2
→ ∞), Eq. (3) simplifies to a quadratic, corresponding to the formation of only the 1:1 complex:

0  K D1 [P] t   K D1  [P]t  [D]t  [P]  [D]2

3.5.7

(4)

Competition ESI-MS

Analyses were performed on a Waters Q-TOF (quadrupole orthogonal acceleration–timeof-flight) micro mass spectrometer equipped with an ESI source in positive ion mode. Samples
were dialyzed extensively against 0.01 M NH4HCO3 (pH 8) and introduced into the ion source by
direct infusion at a flow rate of 5 µl/min. The instrument operation parameters were optimized as
follows: capillary voltage of 2800 V, sample cone voltage of 25 V, extraction cone voltage of 2.0
V, de-solvation temperature of 90°C, source temperature of 120°C, and collision energy of 3.0 V.
Nitrogen was used as nebulizing and drying gas on a pressure of 50 and 600 psi, respectively.
MassLynx 4.1 software was used for data acquisition and deconvolution. A multiply charged
spectra were acquired through a full scan analysis at mass range from 300 to 3000 Da and then deconvoluted by a maximum entropy procedure (223) to the zero-charge spectra presented. Samples
were diluted with dialysate to different concentrations for acquisition and data processing under
the same condition.
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3.5.8

CD spectroscopy

Spectra were acquired in 10 mM NaH2PO4/Na2HPO4 (pH 7.4) plus NaCl as a function of
concentration or temperature as indicated in the text in a Jasco J-810 instrument. Thermal
denaturation experiments were performed at 45°C/hour with a response time of 32 s. The path
length for near-UV scans was typically 1 or 0.1 mm for far-UV scans. Spectral analysis following
blank subtraction and normalization concerning path length and concentration was performed by
singular value decomposition as follows. For each experiment, a matrix A with column vectors
represented by CD intensities at each protein concentration was factorized into the standard
decomposition

A= UΣVT

(5)

Where the left-singular unitary matrix U contained the orthonormal basis spectra ui scaled
by the singular values σi from the diagonal matrix Σ. The row vectors in the right-singular unitary
matrix VT gave the concentration- or temperature-dependent contribution of each basis spectrum
to the observed data and is termed as transition vectors vT in the text. For ease and clarity of
presentation, the scaling due to Σ is captured into the transition vector i.e., a = u(σvT) (matrix
multiplication is associative) which does not affect the fitted parameters. The transition vectors
were fitted to titration models describing a two-state transition with dissociation constant K as
follows

X  F1n  X n  X 1   X 1  F1n  X  X 1

(5)
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where X = σvT and the subscripts “1” and “n” refer to monomer and oligomer (n = 2 for
dimerization), respectively. F1n is given by

Kn  nptn 1

(1  F1n )n
F1n

(6)

where F1n is the fractional two-state 1-to-n oligomer at equilibrium, pt is total protein
concentration. As detailed elsewhere (222), a fundamental feature of Eq. (6) is that dimerization
is uniquely non-sigmoidal on linear scales, which is diagnostic for two-state dimers. Any higherorder oligomers processes are invariably sigmoidal on linear scales.
3.5.9

Nuclear magnetic spectroscopy

NMR experiments were conducted at 25°C using Bruker BioSpin 500, 600, or 800 MHz
spectrometers. For DOSY experiments, unlabeled protein and DNA were co-dialyzed in separate
compartments against the required buffer, lyophilized, and reconstituted to 250 µM in 100% D 2O
before data acquisition at 500 MHz with a 5-mm TBI probe. For 2D/3D experiments, uniformly
labeled ΔN165 and ΔN117 (± unlabeled DNA) were dialyzed against the required buffer at 11/10
excess concentration and adjusted 10% D2O at 400 to 700 µM protein. The dependence of the
DOSY-derived self-diffusion coefficients on total protein concentration were fitted using Eqn. (5)
with X corresponding to the diffusion coefficients of the oligomer and monomer.
1

H-15N correlated measurements were made using a phase-sensitive, double inept transfer

with a garp decoupling sequence and solvent suppression (hsqcf3gpph19). Spectra were acquired
with 1k × 144 data points and zero-filled to 4k × 4k. Steady-state heteronuclear 1H15N-NOE was
acquired at 600 MHz from the difference between spectra acquired with and without 1H saturation
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and a total recycle delay of 3 s. The data was processed with TopSpin 3.2 to extract peak intensities
and fitted as single exponential decays.
Spectra were assigned with purified

13

C/15N-labeled constructs in a standard suite of 3D

experiments: HNCA, HNCACB, HN(CO)CACB, HNCO and HN(CA)CO at 800 MHz using a 5mm TCI cryoprobe for bound protein to DNA and at 600 MHz using a 5-mm QXI probe for
unbound protein. Spectra were processed using NMNRFx software, referenced to DSS, and peak
picked/analyzed with NMRFAM-Sparky. Automated Assignments were made using the
NMRFAM Pine server, and verified manually.
3.5.10 Fluorescence-detected self-association and protein denaturation
The intrinsic fluorescence from three tryptophan residues in the PU.1 ETS domain was
excited at 280 nm and detected at 340 nm with a slit for excitation of 15 nm and 20 nm for emission.
Intensity data recorded in the vertical and horizontal polarizer positions were corrected for the
grating factor and by blank subtraction. Concentration-dependent anisotropies were fitted to Eqn.
(5) and (6), where X = r . For denaturation studies, PU.1 at 100 µM and 1 µM in 10 mM TrisHCl
buffer (pH 7.4) containing either 0.15 M or 0.05 M NaCl was titrated with urea. Blank-subtracted
intensity data was directly fitted with the linear extrapolation method.
3.5.11 Differential scanning calorimetry
Protein samples were exhaustively dialyzed in against 10 mM NaH 2PO4/Na2HPO4, pH 7.4,
and 0.05 M NaCl over 48 h with at least three buffer changes. The final dialysate was reserved and
used to rinse and fill the reference cell as well as a diluent for the samples. Thermal scans were
carried out at 45°C/h from 10°C to 80°C using a Microcal VP-DSC instrument (Malvern). All
scans were carried out only when the baseline was reproducibly flat. Thermograms were fitted to
two-state transition models. Nonpolar and polar solvent accessible surface area (SASA) for
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monomeric ΔN165 was estimated from the solution NMR structure 5W3G (225) based on a 1.4Å probe. SASA for the unfolded state ensemble was provided by the ProtSA algorithm. The change
in SASA in Å was converted to heat capacity change in kJ mol -1 K-1 using coefficients as follows:

 C p0 

 0.32

 0.04   Anonpolar –  0.14  0.04   Apolar

(7)

3.5.12 High-precision densimetry
Solution densities ρ were measured in 10 mM TrisHCl, pH 7.4 at 25°C, containing 150
mM NaCl using an Anton Paar Model DMA-5000 vibrating tube densimeter with a precision of
1.5 × 10-6 g/mL. The partial molar volume of the solute V° is determined from the following
relationship

   0  ( M  V   0 )c

(8)

where  0 is the density of the buffer, c is the molar solute concentration, and M is the
molecular weight of the solute. For a two-state dimeric species, the observed density is analyzed
as follows:

obs  F1n 2  (1  F1n ) 1

(9)

Where F1n is as defined by Eq (6), with n = 2. Since the observed density varies with the
concentration of any species 1 and  2 is each treated as linear functions as described by Eq. (8)
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Figure 3-1 PU.1 transactivation is regulated by negative
(A) The ETS domain (N165) is the only structured and minimal DNA binding unit (PDB: 1PUE).
(B) Left: DOSY NMR titrations of N117 and N165 with cognate DNA yielding equivalence
points at DNA: protein=0.5 and 1.0, corresponding to 2:1 and 1:1 complexes, respectively. The
absence of single global minima at DNA: protein = 1:1 formally excludes the possibility of a 2:2
complex. Right: Fluorescence anisotropy titrations with labeled cognate DNA. Both N117 and
N165 form a 2:1 complex at a single DNA site with different negative cooperativity as defined
by the ratio of the two sequential dissociation constants KD1 and KD2 (dashed lines; see Materials
and Methods). Parametric values are given in table S1. (C) Scheme of negative feedback in PU.1
trans-regulation. A mechanistic link between dimerization and negative feedback predicts a
reduction in PU.1 activity under conditions permissive of an inactive 2:1 complex. (D) Synthetic
PU.1-dependent EGFP reporters. A minimal TATA box was driven by enhancers composed only
of tandem EBS (yellow blocks) spaced 20 bp apart. Hatched blocks represent mutated sites. (E)
Representative flow cytometric data of untreated HEK293 cells and upon transfection with a
constant dose of the 5×EBS reporter and/or up to 25 ng of an expression plasmid encoding fulllength PU.1 (see Materials and Methods). Quadrant Q2 contained the EGFP-positive cells to be
counted out of all PU.1-expressing cells (Q2 +Q3). (F) EGFP fluorescence in Q2 taken over the
summed fluorescence in Q2 +Q3 at 24 hours after co-transfection of the EGFP reporter plasmid
and the indicated dose of PU.1 expression plasmid. Each data point represents the means ± SE of
triplicate or more samples. (G) RT-PCR measurements of pu.1, csf1ra, and e2f1 mRNA abundance
(relative to gapdh) in THP-1 cells induced with PMA following exposure to either doses of a PU.1
inhibitor for 2 hours (left) or a fixed dose of 20 M inhibitor for various periods (right). Cells were
visualized at ×40 magnification after Giemsa staining.
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Figure 3-2 Calibration of transgenic PU.1 dosage
a, to determine the dosage of PU.1 transgene that would yield physiologically relevant levels of
PU.1, transcripts of the pu.1 gene were quantified in two model human myeloid cell lines, under
normal proliferative conditions as well as under induction by 16 nM of phorbol 12-myristate (PA).
Consistent witMh the strong inducibility of PU.1 in primary tissue, PMA induced PU.1 mRNA
transcripts in both cell lines. All samples were presented as means ± SE of at least 3 biological
replicates relative to gapdh. The data establish that a maximum dose of 25 ng (per well of a 24well plate) of the PU.1 expression plasmid in HEK293 (see Materials and Methods) would yield
an expression level comparable to induced HL-60 and non-induced THP-1, but well below levels
in that cell line under PMA induction. b, we then determined whether 25 ng of the PU.1-expression
plasmid would yield a linear dosing range for the λB reporters following transient transfection in
HEK293 cells. PU.1 expression was quantified by its co-translating PU.1 iRFP marker by flow
cytometry. Cells in quadrant Q2 and Q3 represented PU.1-expressing cells. The sum of their counts
was plotted against the plasmid dosage. The line represents a linear fit to the data. c, to crossvalidate the flow cytometric approach, PU.1 abundance was also measured by immunoblotting
transfected HEK293 lysates at 10 µg per lane. PU.1 was probed with a rabbit polyclonal antibody
(Cell Signaling, #2266) followed by an HRP-coupled mouse anti-rabbit secondary antibody (Santa
Cruz). β-actin (loading control) was probed with a mouse monoclonal antibody (Santa Cruz) with
an HRPcoupled rabbit anti-mouse secondary antibody (Santa Cruz). Blots were visualized using
an Amersham Imager 600 and quantified using ImageJ software.
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Figure 3-3 Characterization of a peptide-based PU.1 inhibitor
The synthetic dodecameric peptide nP-1 (Ac-RDYHPRDHTATW-NH2) inhibited cognate DNA
binding by PU.1 in a competitive gel-mobility shift assay using netropsin. Each netropsincontaining lane represented a 2-fold increase in concentration. In the negative control without nP1, PU.1 was displaced by netropsin binding to the DNA minor groove adjacent to the 5’-GGAA3’ consensus. b, Quantification of the mobility shift data shows that nP-1 at 1 µM was highly
synergistic with netropsin, reducing the apparent IC50 by >20 fold. c, Uptake of Cy3-labeled
peptide by THP-1 cells at 10 µM, imaged at 63× magnification.
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Table 2 Primers in RT-PCR experiments
Gene
Sequence
⇆
pu.1

csf1ra

e2f1

gapdh

F

5´-CTC CAG TAC CCA TCC CTG TC-3´

R

5´-CGG ATC TTC TTC TTG CTG CC-3´

F

5´-CAG AGC CTG CTG ACT GTT GA-3´

R

5´-TTG CCC TCA TAG CTC TCG AT-3´

F

5´-AAG GGA AGG AGT CTG TGT GG-3´

R

5´-CGA AAG TGC AGT TAG AGC CC-3´

F

5´-CGG AGT CAA CGG ATT TGG TCG-3´

R

5´-TCT CGC TCC TGG AAG ATG GTG AT-3´

Amplicon, bp

Tm, °C

158

64

263

60

214

64

225

60
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Figure 3-4 The intrinsically disordered PEST domain modifies DNA recognition by PU.1
(A) 1H-15N HSQC of ΔN117 and ΔN165 in the 1:1 complex with cognate DNA. The assignment
of the ΔN165 spectrum was 90% complete. (B) DNA binding by ΔN165 and ΔN117 in 0.1 M and
0.05 M NaCl, showing the impact of the PEST domain on the cooperativity of 2:1 complex
formation. Parametric values of the equilibrium dissociation constants are given in table 3.8.
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Figure 3-5 1H-15N HSQC-detected titration of ΔN117 and ΔN165 by cognate DNA
ΔN117 is in red, ΔN165 in blue. Conditions were essentially the same as the DOSY titration in
Figure 1a (0.15 M NaCl), except uniformly 15N-labeled protein was used at 400 µM.
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Figure 3-6 The disordered PEST domain in PU.1 drives dimerization in the absence of
DNA
a, Concentration-dependent changes in hydrodynamic and volumetric properties by DOSY NMR,
intrinsic Trp fluorescence anisotropy, and high-precision densimetry of ΔN117 in 0.15 M Na + at
25°C. Red curves represent fits of the data to a two-state monomer-dimer transition. b,
Representative zero-charge ESI mass spectra of ΔN117 at 13 and 840 µM total concentration,
normalized to the height of the monomer (17 kDa) peak. The ratios of the integrated dimer-to
monomer intensities (MW showed) were French-curved to guide the eye. c, Far-UV CD spectra
of ΔN117 and ΔN165 at 25 µM, plotted on a per-molecule basis to highlight the contribution of
the N-terminal residues. d, Concentration-dependent, per-residue spectra of ΔN117 and ΔN165
(left). Dimerization as revealed by the singular value decomposition of the ΔN117 spectra and
fitted to a two-state transition. e, 1H-15N HSQC of 400 µM ΔN117 and ΔN165 at 0.15 NaCl. Under
these conditions, ΔN117 was predominantly dimeric and ΔN165 was monomeric. The assignments
shown are for ΔN117. Inset, 1H-15N-NOE for ΔN117 and ΔN165.
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DNA binding data were fitted to titration models as detailed in Materials and Methods. The
choice of fitting with one or two dissociation constants was made based on the magnitude of
anisotropy change and statistically by the Fisher’s F-test on sums of squares at p = 0.05.
Estimates in µM are given as means ± SE of three or more replicate experiments. n.d., not
detectable.
Table 3 DNA-binding and self-association equilibrium constants of PU.1 constructs
[Na+], M
KD1 and KD2, µM
0.15

0.10

0.05

ΔN117

0.0038 ± 0.0019
7.1 ± 3.3

0.010 ± 0.001 15
±5

0.19 ± 0.05

ΔN165

0.0091 ± 0.0015
1.9 ± 0.9

0.036 ± 0.003

0.13 ± 0.02

sΔN117

0.0051 ± 0.0007
6.0 ± 1.3

0.0074 ± 0.0022
3.5 ± 1.8

sΔN165

0.11 ± 0.03 15
±9

0.13 ± 0.02 32
± 24

D2ΔN117

0.0056 ± 0.0008
6.7 ± 3.2

D4ΔN117

0.013 ± 0.004
108 ± 39

DKCDK monomer

0.013 ± 0.03
2.5 ± 0.4

DKCDK dimer

3.1 ± 0.9
n.d.

R232A/R235A

>0.5
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Dissociation constants of 1:1 and 2:1 complexes in the presence of co-solutes
KD1 and KD2, M

Ovalbumin

BSA

[Co-solute], % w/v
15%

20%

(3.8 ± 0.7) × 10-9
(9.5 ± 1.1) × 10-6

(6.3 ± 0.6) × 10-9
(3.2 ± 0.5) × 10-5

5%

10%

(7.9 ± 1.5) × 10-11
>10-4

(3.0 ± 1.9) × 10-11
>10-4

10%
(1.6 ± 0.7) × 10-8
(2.1 ± 1.5) × 10-6

PEG 8K

10%
Ethylene glycol

(7.0 ± 1.6) × 10-9
(6.2 ± 1.6) × 10-6

[NaCl] = 0.15 M
Two-state dissociation constants of ΔN117 and ΔN165 constructs by CD spectroscopy
(Affinities at 0.15 M NaCl unless otherwise indicated)
Construct

K2, µM

ΔN117 (wildtype)

46 ± 20

sΔN117

≫300

D2ΔN117

25 ± 3

D4ΔN117

13 ± 1

ΔN165 (wildtype)

≫800
202 ± 72 (0.05 M NaCl)

sΔN165

n.d.
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Figure 3-7 Purity of recombinant PU.1 constructs
a, one µg of each purified PU.1 construct was resolved in a 15% polyacrylamide gel (29:1) under
standard denaturing (0.1% SDS) and reducing conditions (0.5 mM TCEP). b, MALDI-ToF mass
spectrum of ΔN117.

103

Figure 3-8 Mutations demonstrate non-equivalent PU.1 dimers with and without of DNA
a, Far-UV CD spectra of the DNA-bound ΔN165 upon subtracting the spectrum of the cognate
DNA acquired under identical conditions (75 µM, 0.15 M Na+). b, Residues involved in the
DKCDK and the binding-deficient mutant (R230A/R233A). The structure is homology-modeled
against the co-crystal 1PUE. c, Purification of the DKCDK mutant by ion-exchange
chromatography under non-reducing conditions. The lysate was loaded at 0.5 M NaCl and
extensively washed before elution over a linear gradient to 2 M NaCl. SDS-PAGE of purified
fractions are shown. Fractions containing primarily monomer (e.g., 1 and 2) or dimers (e.g., 5
onwards) were concentrated and dialyzed separately into a buffer containing 0.15 M NaCl with or
without 5 mM DTT, respectively. d, CD spectra of the DKCDK monomer (top) and dimer (bottom)
under various conditions with wild type ΔN165 as reference. The spectrum for the DKCDK
monomer was less well resolved due to the presence of DTT which contributed to the total
absorption of the sample at 50 µM protein. See the text for details. e, Fluorescence anisotropy
measurements of cognate DNA binding by monomeric and dimeric DKCDK with wild type
ΔN165 as reference. f, CD spectrum of 25 to 100 µM of the R230A/R233A mutant, with ΔN165
at 25 µM as reference. g, DNA loading by the R230A/R233A mutant in the presence of wild type
ΔN165 (solid symbols). Concentrations of the mutant and wild-type protein that individually failed
to bind DNA collaborated to bind DNA as a hetero-complex. h, Proposed model for the formation
of two non-equivalent PU.1 dimer: an asymmetric one in the 2:1 DNA complex and a symmetric
one without DNA.
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Figure 3-9 Dimerization of the DNA-binding domain of PU.1 is electrostatically
mediated and conformationally destabilizing
a, CD-detected titration of ΔN167 at 50 mM NaCl from 25 to 800 µM. b, Analysis of the titration
by singular value decomposition yields a two-state transition with a dissociation constant K2 of
202 ± 72 µM. c, 1H-15N HSQC as a function of salt from 25 to 500 mM NaCl. Residues with the
strongest 1H-15N chemical shift perturbations (CSPs; Y173, M223, G239, V244, and L248) are
boxed. Inset, salt dependence of the CSPs of these residues. d, Summary of the residue CSPs with
the average %SASA from the unbound NMR monomer, 5W3G. Residues above a 0.5 ppm cutoff
are colored in dark blue and the subset of internal residues (<35% SASA, based on the termini)
are marked with yellow circles. Residues implicated in the DNA-bound dimer are marked with
green circles. e, Mapping of the high-CSP residues to 5W3G. Green residues mark known residues
involved in the DNA-bound dimer (20). f, Chemical shift-derived secondary structure prediction
via the chemical shift index using 1H and 15N signals. The color scheme follows the HSQC in
Panel C. Regions with significant changes in secondary structure are marked by arrows. g, NearUV CD-detected thermal melting of ΔN117 and ΔN165. Two salt concentrations were evaluated
for ΔN165 (blue and grey). Inset, Representative near-UV CD spectra. h, DSC thermograms (solid)
for ΔN165 under conditions (salt and concentrations) in which the protein was primarily
monomeric or dimeric. The ΔCp values are given in kJ (mol monomer)-1 K-1. Dotted curves
represent the two-state transition for a monomer (black) and dimer (blue). i, Trp fluorescencedetected denaturation by urea of ΔN117 and ΔN165 at two monomer concentrations. Curves
represent fit to the linear extrapolation model for a two-state dimer. The marked concentrations
represent urea concentration at 50% unfolding.
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Figure 3-10 Spectral analysis of far-UV CD of ΔN165 in 0.15 and 0.05 M NaCl
a, Blank subtracted, concentration-corrected spectra. Absorption by Cl - limits the useable ranges
of wavelengths and protein concentration in 0.15 M NaCl to those shown. b, following singular
value decomposition (see Materials and Methods for details), the two most dominant basis
vectors in U. c, Progress curves of the concentration dependence as represented by the transition
vectors VT. The 0.05 M transition was fitted to a two-state dimer. The dissociation constant is
202 ± 72 µM.
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Figure 3-11 Salt-dependent line broadening of methyl protons in ΔN165
a, Methyl protons located at negative chemical shifts of 1H spectra, acquired at 500 MHz, of
identical concentrations (350 µM) of ΔN165 in the presence of 0.025 and 0.5 M NaCl,
respectively. b, the linewidths, converted to Hz = s-1, were fitted to a sum of Lorentzian peaks
(red) from which the full widths at half maximum (Δν ½) were estimated by nonlinear regression.
c, the effective T2* for each peak was then computed by:

T2* 

1
π ½
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Figure 3-12 The short C-terminal IDR is required for DNA-free PU.1 dimerization
a, Superposition of the 10 models in the solution NMR structure of the PU.1 monomer, 5W3G.
The C-terminal IDR is colored cyan. b, Schematic of PU.1 constructs, sΔN117, and sΔN165,
without the C-terminal 12-residue IDR. c, Far-UV CD spectra (left) and urea denaturation curves
(right) of sΔN117 and sΔN165 at 0.15 M Na+. The molarity stated represents urea concentrations
at 50% unfolding. d, Cognate DNA binding by sΔN117 and sΔN165 at 0.15 M Na +. e,
Corresponding data for sΔN165 at 0.05 M Na+. In contrast with ΔN165 [c.f. Figures 3.11a and b],
sΔN165 shows a negligible propensity for dimerization without DNA but exhibits biphasic DNA
binding.
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Figure 3-13 Phosphomimetic substitutions at the PEST domain and charged crowding
demonstrate a general electrostatic basis of IDR/ETS interactions
a, Schematic of the phosphorylated Ser residues in human PU.1, marked by green pins. The Ser
→ Asp substituted positions in D2ΔN117 and D4ΔN117 are shown. b, D2ΔN117 and D4ΔN117
exhibit enhanced dimeric propensities without DNA relative to ΔN117 [c.f. Figure 3.7d]. c,
D2ΔN117, and D4ΔN117 are progressively impaired in 2:1 DNA complex formation. d, the anionic
crowders ovalbumin, and BSA modulate DNA binding by ΔN117 in a similar way as the
phosphomimetic substitutions on ΔN117, to an extent that correlates with their sizes and low
isoelectric points. Inset, stoichiometric determination using 1 µM DNA (first binding transition in
the case of ovalbumin). The spacing of the ordinates is identical to the main plots. The surface
potentials of the structures were computed by APBS at 0.15 NaCl.
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Figure 3-14 Effect of macromolecular crowding on dimerization of ΔN165 in the
unbound and DNA-bound state
a, Charge-neutral crowding with PEG 8K on cognate DNA binding by ΔN165. Representative
titrations in the presence of 10% w/v ethylene glycol (EG) showed destabilization consistent with
osmotic stress as previously reported (Poon, J Biol Chem 287, 18297-18307, 2012). The presence
of the same mass concentration of polymeric PEG 8K was similar. In both cases and stark contrast
with the acidic crowder BSA, the 2:1 complex was preserved. b, 19F NMR reveals conformational
perturbations in ΔN165 consistent with unbound dimer formation. The three Trp residues (190,
191, and 213) in ΔN165 were isotopically labeled with 5-fluoroindole in minimal M9 media.
Chemical shifts were acquired at 0.15 M Na+ in D2Oreconstituted buffer and referenced against
the published value for 5-fluoroindole in 90% D2O (Sarker et al., Biochemistry 55, 3048-3059,
2016). No concentration-dependent chemical shift perturbation (CSP) was detectable at 350 and
50 µM at ΔN165, in contrast with the presence of 5% w/v BSA. Line broadening in the BSAcontaining sample was expected due to increased viscosity.
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4

DYNAMIC MECHANISMS OF DNA TARGET SELECTIVITY BY THE ETSFAMILY TRANSCRIPTION FACTOR PU.1
This work is still in the writing phase prior for submission

4.1

Introduction
Transcription factors represent a significant functional component of the eukaryotic

proteome. In virtually all human tissue types, transcription factors alone comprise ~6% of
expressed genes (25) As DNA-binding proteins, DNA sequence selectivity, summarized
bioinformatically as “motifs,” represents core attributes in our knowledge base of transcription
factors (34). These factor-binding motifs, for which comprehensive collections and catalogs have
been curated, are indispensable for the functional assignment of non-protein-coding sequences. At
the same time, motif matching with enriched sequences in ChIP-seq data (245) has established the
importance of intrinsic target specificity in transcription factor function in vivo (246). The
structural origins of the DNA sequence preferences of transcription factors (39) as primarily
embodied by their DNA-binding domains (DBDs, are therefore fundamental to our understanding
of gene regulation.
A long-standing challenge in transcription factor/DNA recognition is posed by the
selectivity mechanisms of proteins harboring DBDs that are highly structurally homologous. The
ETS family of transcription factors, of which 28 members are expressed in humans and are found
in every major tissue, has been an important model for this problem (110,247,248) ETS proteins
share a structurally conserved DNA binding domain, also referred to as the ETS domain of ~85
residues (109). The ETS domain is a winged helix-turn-helix motif (wHTH) where the recognition
helix (H3) inserts into the DNA major groove harboring the core consensus 5’-GGA(A/T)-3’ and
makes additional backbone-mediated contacts with sequences flanking both ends of the consensus.
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The flanking sequence variation of ETS-binding motifs represents the primary basis of
classification of ETS family members into four classes (110). DNA preferences among ETS
domains correlate with their amino acid sequence alignment, which is strongly conserved near the
consensus-contacting recognition helix H3 [Figure 4.1], but significantly divergent elsewhere.
To date, the mechanisms of flanking sequence discrimination by ETS proteins remain
enigmatic. The markedly segmented pattern of ETS/DNA contacts, where flanking bases are
bound via backbone phosphate or sugar contacts, have suggested an indirect readout mechanism
in which the sequence-dependent propensity of DNA conformation (249). While this interpretation
dovetails with the currently favored emphasis in DNA shape (250) structural definition of this
propensity has remained unclear. Moreover, several co-crystallographic (4MHG, of ETV6) and
solution NMR structures (2STW, of Ets-1) of ETS members show evidence of contact with
flanking nucleobases. These examples of direct readout at flanking positions involve residues near
the transition of H3 and a preceding extended loop (the turn-helix in wHTH). In NMR structures,
the sidechains of these residues are notably dynamic, exhibiting various conformations that
alternately contact a 5’-flanking nucleobase or avoid DNA altogether. These features, together
with the absence of a viable indirect readout mechanism, prompted us to ask whether dynamic
direct readout might serve as the mechanism of flanking sequence selection. To this end, an
attractive model is PU.1, an ETS-family relative (Class III) that exhibits preferences for 5’flanking sequences that differ distinct from the vast majority of its ETS relatives (Classes I and II).
DNA-bound PU.1 was the first ETS domain whose structure (1PUE) was solved by
crystallography (143). Unfortunately, the recombinant crystallized domain carried a Gln→Glu
point mutation (murine residue 228) in the same neighborhood (loop-H3) where direct readout of
5’-flanking regions was implicated. In a recent solution NMR structures of the unbound state
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(5W3G), which harbored the native Gln, this residue exhibited strong sidechain conformational
dynamics (225). To resolve the role of this Gln in flanking sequence selection, we therefore reexamined the DNA-bound complex crystallographically. We co-crystallized the sequence-correct
ETS domain of human PU.1 (which is identical to the murine ortholog) with the highest-affinity
DNA target (197), with a view of maximizing the potential for capturing direct readout. This new
co-crystallographic structure of PU.1/DNA (PDB code 7K1T), solved to a resolution of 1.3 Å,
unveiled how PU.1 recognized a highly preferred flanking sequence by direct readout via its native
loop-H3 Gln residue (human position 226).
4.2

Results
4.2.1

Comparison of high-affinity PU.1/DNA co-crystal structures

The new bound structure of PU.1 (7K1T) at 1.34 Å [Figure 4.2A] [Table 4] resolution
presents a thorough profile on the binding properties of PU.1, hydration patterns of the complex,
and putative placement of hydrogens during crystallographic refinement [Figure 4.3]. The 7K1T
complex can be easily compared to its predecessor complex 1PUE solved in 1996 (143) [Figure
4.2B] and to some extent to the unbound NMR structure (PDB: 5W3G) solved in 2017 [Figure
4.2C]. The high resolution structure 7K1T is composed of PU.1 (human residues 169-259) and
DNA 16 bp (5’ AATAAGCGGAAGTGGG, 3’ TATTCGCCTTCACCCT), 1PUE represents PU.1
(human

residues

169-256)

and

16

bp

DNA

(5’AAAAAGGGGAAGTGGG,

3’

TTTTCCCCTTCACCCT) and 5W3G represents unbound PU.1 (human residues 165-270).
The two crystallographic complexes differ in many aspects: 7K1T is a monomer in the
asymmetric unit, with a known biological DNA flanking sequence of 5’AGC and a longer
sequence of protein by three residues at the C-terminus that initiate a formation of Helix 4. In
comparison 1PUE has two monomeric complexes in the asymmetric unit, a DNA flanking
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sequence optimized for crystallography, and the formation of helix 4 at the c-terminus is not
present in the structure. Interestingly the crystal packing of 7K1T [Figure 4.4] and 1PUE differs
with 7K1T crystallizing in P 1 21 1 space group (density of unit cell being 3.84g/cm 3) and 1PUE
crystallizing in C 1 2 1 space group (density of unit cell being 1.54 g/cm 3) partially giving rise to
the difference in resolution.
The differences in DNA sequence and crystal packing between 7K1T and 1PUE drive
slight changes in the B-factor distribution on the DNA [Figure 4.2D]. The DNA for 1PUE gives a
sharp contrast in the distribution of B-factors (red: high B-factors; blue: low B-factors) where the
high B-factors occur in the flanking bases and the low B-factors in the nucleotides adjacent or
complementary to the core consensus 5’-GGAA-3’. By comparison, 7K1T does not exhibit a sharp
transition, instead a gradual change throughout the DNA backbone is observed. Comparing the
individual base pairs of 1PUE and 7K1T [Figure 4.5] revealed the base pairs of the core consensus
sequence overlap closely, while the flanking nucleotides are not superimposable. A closer look at
the crystal packing interface reveals that the DNA in 7K1T form three non-Watson and Crick
(WC) base pairs [Figure 4.6]. Along with the differences in sequence, as well as the formation of
the non-WC base pairs, this evidence serves as an explanation for the minor differences in DNA
B-factors as well as structure.
To investigate whether the changes in crystal packing and DNA sequence impacted the
protein structure of 7K1T, we aligned 7K1T and 1PUE and found the RMSD to be 0.260 Å. The
different crystal packing environment along with different DNA sequences, indicates that the DNA
binding domain of PU1 is structurally agnostic to both the DNA flanking sequences and protein
environment. This would suggest that small changes in side chains would be mechanistically
responsible for selectivity and changes in flanking sequences.
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Seeing as the difference in sequence and crystal packing did not give rise to large changes
in the structure of the DNA or protein, we decided to create a Ramachandran plot to compare the
two DNA-bound structures (7K1T and 1PUE) with the unbound NMR structure [Figure 4.2E].
Comparing the three structures it was noticed that most of the residues overlapped, indicating a
stable structural core indifferent to experimental conditions, giving further evidence that small
conformational changes of the amino acid side chains are responsible for DNA binding and
selectivity. Most of the unmatched residues are all located in loops: D184 and M185 are present
in the loop between α helix 1 (H1) and β-sheet 1, G218 and R220 are present in the loop between
α helix 2 (H2) and α helix 3 (H3). The remaining residues (G254, E255, V256, G258 and R259)
are located at the C-terminus of the protein in α-helix 4 (H4). A mapping of the residues [inset
Figure 4.2E] visually indicated that the clustering displayed certain patterns.

Furthermore,

comparing the ψ and ϕ angles of 7K1T and 1PUE [Figure 4.2F] all residues with the exception to
those previously mentioned (D184, M185, G254, E255, V256) fall on the correlation line
indicating that the backbone dihedrals angles of both structures are similar. Seeing how at the
macroscopic level, the structural similarity in the backbone dihedrals, not only lends credence to
what can visually be observed, but also provides concrete proof the DNA selectivity is born from
the orientation of the amino acid side chains.
In order to investigate the differences in the sidechains, we examined the sidechain dihedral
angles between 7K1T and 1PUE [Figure 4.2G], and plotted the difference of the χ angles (7K1T1PUE). As a representative, we have shown the residues that are different in at least three out of
four χ angles [Figure 4.2H]. Residue K196 is the only residue that is different in both proteins with
a difference in χ1-4 angles. Residue K222 and R212 are different in three χ angles. Furthermore,
it was noticed during this analysis that R212 and Q226 holds two distinct conformations in 7K1T,
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giving evidence that these residues may be important for driving the selectivity of DNA binding.
With the overall structure remaining unchanged across multiple experimental conditions, the
differences in the amino acid conformations must play a role in DNA recognition and selectivity.
4.2.2

Persistent waters aid DNA selectivity

The biggest difference between the two crystallographic complexes is the mutation of
residue Q226 to E226 in 1PUE while there are no such mutations in 7K1T. Interestingly, this Q226
in 7K1T has two separate conformations (up 42% and down 58%). When aligned with 1PUE and
the average structure of the 5W3G ensemble, we noticed that the “down” position of Q226 in
7K1T aligns with E226 in 1PUE and Q226 of 5W3G. [Figure 4.7]. However, considering that
5W3G is a NMR solution structure it was of interest to investigate the individual conformation
that Q226 occupies in solution [Figure 4.8]. The two conformations of Q226 in 7K1T occupy the
conformations shown in the NMR solution structure. Furthermore, in the crystallographic “up”
position of 7K1T, Q226 hydrogen bonds to DG6 and DG8 on the 5’ portion of the DNA. This
secondary position, could act as a potential scanning mechanism to recognize sequences upstream
of the core consensus sequence. Additionally, residue Q226 is only conserved in Class III ETS
proteins, with E/D being prevalent in the other classes suggesting that it is important in selectively
facilitating DNA binding in a sequence specific manner.
The high resolution of 7K1T allows us to place more crystallographic waters and is a good
opportunity to identify water bridging contacts of PU.1 to DNA [Figure 4.9A]. The
crystallographic waters also allow us to compare with 1PUE to identify structurally conserved
waters that are important for DNA binding. Utilizing the clustering algorithm DBSCAN, we
compared waters with different cutoffs from 1.0 Å to 0.3 Å [Figure 4.9B]. As predicted, as the
cutoff for clusters decreased, the number of clusters decreased from 15 to 3 clusters. The lowest
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cutoff allowed us to easily identify waters that were positioned in the same spot of the crystal
structure, while the cutoff of 0.7 Å was chosen so as to start identifying water networks.
Interestingly, at the strictest cutoff of 0.3 Å, one of the three water clusters interacts with Q226
[Figure 4.9C] in its “up” position when it binds to DNA. This indicates that the position of Q226
that binds to DNA and the water mediated contact is highly important to the stability of the protein
for DNA binding. This water also interacts with R233 a universally conserved residue [Figure
4.9D] that is known to bind to the second guanosine of the consensus GGAA (7K1T and 1PUE).
This structural evidence suggests that water is important for maintaining Q226 and R233
interaction while they respectively bind to DNA.
4.3

Discussion

PU.1 recognizes DNA through its recognition helix 3 (H3) where R230 and R233 directly interact
with the cognate DNA sequence GGAA. PU.1 has a preference of DNA in the 5’ flanking sequence
(197) for high affinity binding. Its inclination to bind purines 5’AXC/A (where X is G or A) has
been demonstrated by DNA binding experiments (197). However, identifying a specific residue
and binding mechanism has proven to be elusive. We set to determine the selectivity of PU.1 by
co-crystalizing the ETS domain (human residues 169-259) and high affinity 16 bp DNA 5’AGC.
The crystal structure PDB code 7K1T demonstrated that the residue Q226 occupies two distinct
conformations to which one of them makes direct contact with DNA at the Guanine base (DG6).
While the 42% occupancy of Q226 interacts with DNA the other 58% occupancy interacts with a
dynamic water in the downward position. Q226 is far from the crystal contact which means that
the dynamics of the conformation observed are not a crystal packing artifact. This was also
demonstrated by the comparison of the NMR structure 5W3G where the motion of Q226 in
solution shifts between the two crystallographic conformations.
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The high resolution of the new structure 7K1T gives insight into the hydration patterns missed
previously by 1PUE. Waters in PU.1 serve as water-bridges between protein and DNA (251) as
part of the high affinity DNA binding. It is important to distinguish dynamic waters vs persistent
waters in crystallographic experiments as the later one is crucial for DNA binding. Comparing the
two structures (7K1T and 1PUE) we determined at 0.3 Å cutoff the persistent waters that serve as
links between residues and base pairs. A persistent water was found to bridge Q226 and R233
together while they individually contact DNA. This connection leads us to propose a selectivity
mechanism by Q226. On the downward position Q226 scans DNA through dynamic waters and
once it recognizes the purines in the 5’ flanking sequence it allows for R233 to bind to the core
consensus first guanine GGAA. The water network in the DNA major groove between protein and
DNA creates stability once PU.1 recognizes its DNA target. These persistent waters are also
present in 1PUE however, there is no connection between the water, point mutation E226, and
R233. PU.1 and its subfamily members of Class III are the only ones with a glutamine residue in
that position while the rest of the family (90% of family) has a glutamic acid or aspartate. This
distinction makes it easier to understand why PU.1 prefers a dynamic glutamine to be able to scan
DNA for a purine in the 5’flanking sequence while interacting with water that bridges a universally
conserved residue such as R233.
4.4

Methods and materials
4.4.1

Nucleic acids

Deoxynucleotides for co-crystallization were prepared by solid state synthesis and purified
by reverse-phase HPLC by Integrated DNA Technologies (Coralville, IA). Lyophilized DNA was
re-dissolved and annealed in Buffer H150 (10 mM HEPES and 0.15 M NaCl adjusted to pH 7.4
with NaOH). The molecular cloning of the wild type ETS domain of human PU.1 (residues 165 to
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270, termed ΔN165) has been previously described (155). Point mutants of ΔN165 were generated
following a PCR-based strategy and cloned into pET28b or pCDF-1b vectors (Novagen) as
previously described (78). Constructs were verified by Sanger sequencing.
4.4.2

Protein purification

Heterologous over-expression in BL21(DE3)pLysS Escherichia coli and purification was
performed as described previously (155). In brief, cultures in LB medium were induced with 0.5
mM isopropyl β-D-1-thiogalactopyranoside at an OD600 of 0.6 for 4 hours at 25°C. Harvested cells
were re-suspended in Buffer P (10 mM NaH2PO4/Na2HPO4, pH 7.4, and 0.5 M NaCl) containing
1 mM PMSF and lysed by sonication. The lysate was cleared by centrifugation and loaded onto
Sepharose SP (GE HiTrap) equilibrated with Buffer P. After washing, the protein was eluted along
a linear NaCl gradient in Buffer P under the control of a Bio-Rad NGC instrument. Following
characterization by SDS-PAGE and mass spectrometry, the purified protein was exhaustively
dialyzed against Buffer H150. PU.1 concentration was determined by UV absorption at 280 nm
based on an extinction coefficient of 22,460 M -1 cm-1.
4.4.3

Crystallization

The PU.1ΔN165: DNA complex was formed by gentle equimolar mixing of PU1 and
duplex DNA at 400 µM each. Crystals were grown by vapor diffusion at 298 K in a hanging drop
comprised of a 1:1 mixture of protein: DNA complex with mother liquor containing 100 mM
sodium acetate and 2.5% PEG 3350. Prior to freezing, 2 µL of cryoprotectant solution containing
100 mM sodium acetate, 2.5% PEG 3350, and 20% glycerol was laid on top of the hanging drop
and the well closed for 1 hour of incubation (4 µL total volume, 10% glycerol concentration). After
1 hour, crystals were transferred to the above 20% glycerol solution prior to freezing.
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4.4.4

Data collection

X-ray diffraction data sets were obtained using a Pilatus3 6M 25 Hz detector at the
Berkeley Center for Structural Biology (BCSB) Advanced Light Source on the 5.0.1 beamline at
a fixed wavelength of 0.977408 Å with an oscillation angle of 0.25°.
4.4.5

Data processing

The diffraction data was processed using the XDS package (252) and was scaled using
Aimless in the CCP4 package (253). Molecular replacement was then performed using 1PUE
(downloaded from the RCSB protein databank) as the search coordinates in the PHENIX suite
(254) with maximum-likelihood procedures in PHASER. Twenty-five rounds of refinement was
then carried out using phenix refine (254) and model building was done with Coot (255). A
summary of crystallographic data is shown in Table 4. Structures of atomic coordinates were
rendered using PyMOL (v2.4.0, Schrodinger).
4.4.6

Data analysis

4.4.6.1 Analysis of water clusters
The analysis of the water clusters was done using PDBs (1PUE and 7K1T). The protein
chain of 1PUE was aligned to the single chain of 7K1T using the align function in PyMol v2.4.0
with careful consideration of the waters associated to each chain. Separate PDBs were made for
each of the aligned chains which included all of the waters. The following analysis was done with
code written in Python v. 3.7 using the libraries Biopandas and SciKitLearn (256,257). Biopandas
allows for the conversion of a pdb file into an easily workable pandas dataframe, while SciKitLearn
was used for DBSCAN the clustering algorithm. In order to identify water clusters only between
different pdb files the DBSCAN algorithm was employed with different eps (distance cutoff) and
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minimum number of samples. All of the code for the analysis can be found in the repository
www.github.com/rgumpper/water_analysis
4.4.6.2 Analysis of Dihedral angles
The dihedral angles were calculated using the R programming language (v4.0.0) and the
bio3d library (258). The torsion.pdb function was used to calculate the dihedral angles and were
output into an excel file for further plotting and analysis.
4.4.6.3 Average NMR structure
The average structure of 5W3G was done by calculating the average position of each
atom across each frame of the deposited pdb file. Biopython (259) was used to aid in reading the
structure and calculating average positions. The code for this calculation can be found in the
repository www.github.com/rgumpper/average_pdb
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Figure 4-1 Recognition helix of ETS family alignment
All the ETS members are aligned for comparison of the recognition helix (H3). There are only 4
residues universally conserved (assigned black stars, *) throughout the helix. The residue Q226
(human numbers for PU.1) only present in Class III is shown with a red star, *
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Figure 4-2 PU.1 crystal structure comparison
A, The new PU.1 crystal structure (PDB code 7K1T). B, previously solves structure of PU.1,
(PDB code 1PUE) which has two monomeric asymmetric units. C, the solution NMR structure
5W3G. D, B-factor putty representation of 7K17 and 1PUE
E, The Ramachandran plot of backbone dihedrals of 7K1T, 1PUE and 5W3G. F, Dihedral angles
ψ (7K1T vs. 1PUE) and ϕ (7K1T vs 1PUE) G, sidechain dihedral angles of all the residues 7K1T
-1PUE plotted H, Residues K196, K222 as representative residues with the most χ angle
differences between 7K1T and 1PUE
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Table 4 Crystallographic table
Wavelength (Å)
Resolution range (Å)
Space group
Unit cell (Å)
Unit cell (o)
Total reflections
Unique reflections
Multiplicity
Completeness (%)
Mean I/sigma(I)
Wilson B-factor (Å2)
R-merge
R-meas
R-pim
CC1/2
CC*
Reflections used in refinement
Reflections used for R-free
R-work
R-free
CC(work)
CC(free)
Number of non-hydrogen atoms
 macromolecules
 ligands
 solvent
Protein residues
RMS(bonds) (Å)
RMS(angles) (o)
Ramachandran favored (%)
Ramachandran allowed (%)
Ramachandran outliers (%)
Rotamer outliers (%)
Clashscore
Average B-factor (Å2)
 macromolecules
 ligands
 solvent

7K1T
0.977408
39.7 - 1.34 (1.388 - 1.34)
P 1 21 1
42.914 60.587 44.484
90 116.818 90
85650 (5321)
44340 (3591)
1.9 (1.5)
96.97 (78.81)
37.50 (2.66)
17.38
0.009791 (0.3066)
0.01385 (0.4336)
0.009791 (0.3066)
1 (0.852)
1 (0.959)
44282 (3589)
1950 (166)
0.1298 (0.2195)
0.1607 (0.2573)
0.980 (0.942)
0.972 (0.906)
1688
1399
1
288
91
0.009
1.13
97.75
2.25
0
0
3.53
26.07
22.9
63.62
41.33
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Figure 4-3 Refined hydrogens in Histidine
There are two Histidine residues in PU.1 ETS domain; H205 and H211. Due to the high resolution
of the crystal structure 7K1T we added hydrogens in the refinement. By increasing the countering
levels, we can see that both H205 and H211 are deprotonated.
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Figure 4-4 Crystal packing of 7K1T and 1PUE
A. Crystal packing of 7K1T shown with the single symmetric unit in color (blue) and the packing
in transparent gray. The figure is rotated 90 degrees on the y-axis for a better side visual packing.
B, previously solves structure of PU.1, (PDB code 1PUE) which has two monomeric asymmetric
units. The figure is rotation of 90 degrees for a side view. The two asymmetric units are shown
in green and the packing in transparent gray.
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Figure 4-5 DNA comparison of 7K1T vs 1PUE
The backbone and bases of the two DNA (7K1T and 1PUE) compared indicate that the core
consensus of GGAA overlap well with one another while the flanking region does not.
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Figure 4-6 PU.1 7K1T shows structural differences due to the non-Watson and Crick base
pairs: Two adjacent crystallographic subunits of 7K1T with DNA colored light blue and light
orange. The 2Fo-Fc map is shown with increasing contouring level (σ) indicates that a charge
cannot be unambiguously assigned.
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Figure 4-7 Q226 has two distinct conformations
All three; 5W3G in salmon color, 1PUE in green and 7K1T in blue were superimposed for
comparison of residue Q226. In both WT structures 5W3G and 7K1T there is a Q226 while in
the mutation of 1PUE there is an E226 7K1T shows two conformations of Q226, one at 42% in
which the residue interacts with DNA at position DG6 and the other at 58% where the residue
does not interact with DNA.
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Figure 4-8 NMR ensemble aligned to 7K1T
NMR solution 5W3G has 10 ensembles (shown in salmon color) which are overlapped with 7K1T
to monitor only Q226 that ranges between the two boundaries of the crystal structure.
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Figure 4-9 Water mediated contacts stabilize the 7K1T complex
A, All the waters bridging protein and DNA shown cyan balls, appear in the major groove around
the H3. B, Comparing the waters between 7K1T and 1PUE at different cutoff (from 1.0 Å to 0.3
Å) monitoring the persistent water cluster. C, the interaction of Q226 in the upward position
contacting DNA and a water that is persistent at 0.3 Å. In the downward position Q226 does not
interact with DNA but a dynamic water. D, a schematic of water network and PU.1 interaction
with DNA, through Q226 sharing a water bridge with universally conserved R233.
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5

SUMMARY

PU.1 is a vital transcription factor as it is responsible for the self-renewal of hematopoietic stem
cells as well as the differentiation of both branches of lymphoid and myeloid pathways (213).
Homozygous PU.1 is lethal to the fetus (260), while heterozygous PU.1 patients will survive with
underlying conditions. Experiments in which the gene of PU.1 was “knocked-out” in mice
showed an early onset of acute myeloid leukemia (AML) (216) a likely reflection on human
AML. The de-regulated activity of PU.1 is also been shown in a handful of diseases such as
lymphoma, myeloma, Alzheimer’s disease to name a few (156-158,214-217). Therefore, the
activity of PU.1 is extremely important for normal hematopoietic cells to sustain life. The activity
of a transcription factor can be determined by two important factors: the expression of that factor
and the real-time regulation upon binding to its target DNA. The expression of PU.1 has been
exhaustively studied as I have demonstrated from the introduction of this dissertation as well as
in the introduction of both chapters 2 and 3. However, the mechanisms for the real-time regulation
of PU.1 has been lacking in the literature. We set out to determine what the regulatory mechanism
of PU.1 is at its DNA/protein level and its molecular interactions.
In chapter 2, we focused on the hydration of PU.1 in comparison to paralog ETS-1, both
proteins belonging to the same ETS family. In numerous papers comparing ETS family members,
PU.1 and ETS-1 have always shared the spotlight as the two have the sharpest contrast. Their
DBD is the most phylogenetically distant in the family (159) but while their tertiary structure
looks identical when bound to DNA (179). As an experimental model, both PU.1 and ETS-1 have
a highly conserved tyrosine (Y) in their DNA binding affinity motif, Y252, and Y412
respectively, which make a water-mediated contact with the phosphate backbone of DNA.
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Therefore, disturbing that contact by mutating the tyrosine into phenylalanine (Y->F) and
observing the effect of both proteins under osmotic stress will provide insight into how these
mutants behave in osmotic stress. For PU.1 at normal osmotic pressure the mutation, the Y252F
showed no difference in DNA binding between the wild-type and mutant, indicating that other
forms of PU.1 may exist. While the ETS-1 Y412F mutation perturbs binding at normal osmotic
pressure. Under high osmotic pressure, the DNA binding of the mutant is weaker than the wild
type, indicating that PU.1Y252F is an osmotic sensor. In contrast, ETS-1 under high osmotic
pressure is sparsely hydrated, and binding is maintained primarily by direct contacts, so the
Y412F mutant induces dynamics to the protein at a distal site away from the DNA binding site.
The mutation of the conserved Tyrosine residues gave us an insight into the hydration
patterns of both ETS proteins with lessons to remember; the ETS homologs, despite their similar
DNA-bound structures, recognize target DNA sites by distinct mechanisms.
In chapter 3 we tackled the mammoth hypothesis that PU.1 forms a dimeric complex at a
single specific DNA binding site in a sequential manner (163,164) as part of its regulatory
mechanism in real-time. Like the majority of transcription factors, PU.1 possesses a single wellstructured domain, the DBD (45). The rest of the protein is intrinsically disordered as it tethers
the ETS domain. On the N-terminus of the ETS domain, there is the PEST region which is highly
acidic while the C-terminus there are 12 residues that do not seem to undergo any conformational
structure. The experiments carried out were various utilizing synthetic enhancer elements
consisting only of tandem copies of the EBS, cell lines that natively express PU.1, and a diverse
array of biophysical techniques to demonstrate that PU.1 forms an inactive complex when bound
as a dimer to DNA. This inactive 2:1 complex is apparent through negative feedback and the
active 1:1 complex is an intermediate that cannot be bypassed. Furthermore, we found that PU.1
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also can form an unbound dimer that is electrostatically mediated. The unbound dimer is
symmetrical and does not involve the PEST region as it remains disordered in the dimeric
complex. Additionally, the unbound dimer is thermodynamically less stable than the counterpart
monomer indicating that it serves as a reservoir form of PU.1 ready to dissociate when needed.
A balancing regulatory mechanism surfaces between the inactive 2:1 complex, acting as
negative feedback, and the inactive unbound dimer as a reservoir of protein when concentrations
are high. These methods of regulation are all mediated by the intrinsically disordered regions of
PU.1. Environmental factors favor one side of the balance (DNA) or the other (unbound) such as
salt, concentration, and crowding agents. When truncating the C-terminal 12 residues we see that
the balance shifts towards the DNA favored dimer while when phosphomimetic mutations of
select PEST residues favor the apo dimeric complex. Furthermore, we demonstrated that these
two dimeric complexes (with or without DNA) are not structurally the same as the unbound is
symmetrical and the bound asymmetrical. Interestingly enough the protein will not undergo a
transition of unbound dimeric PU.1 straight to dimeric complex with DNA creating a typical
thermodynamic closed system. Instead, PU.1 undergoes an unfolded state ensemble explained by
the principle of microscopic reversibility as it clarifies why the dimer is destabilized compared
to the unfolded concerning the monomer. This also explains how the unfolding of the ETS domain
justifies the unfolding ΔN117 dimer by mitigating the electrostatic repulsion.
This insight into the real-time regulatory mechanism of PU.1 gives rise to many questions
regarding Type I (45) proteins and how PU.1 may exemplify a general class of electrostatic
interactions by tethered IDR/DBD a mechanism. These IDRs are a novel drug target as they shift
the equilibrium between active and inactive complexes. Finally, on a much bigger scale, we can

134
apply our current knowledge of PU.1 dimer formation to target gene therapy in heterozygous
patients removing the faulty allele from the protein pool.
5.1

Where to next?
As often happens in life the moment a question is answered, another one immediately

arises. We proposed a model for self-regulation of PU.1 by its intrinsically disordered regions
and clarified some key residues crucial for osmotic sensitivity. The next big task is to identify the
residues in both the PEST region and ETS domain that interact with one another to form the
dimeric complexes. The PEST region is highly acidic and the ETS domain is basic with the
highest cluster of basic residues in helix 3 (H3), which makes direct contact with the major groove
of DNA. We hypothesize that the PEST residues interact with H3 in the unbound form, protecting
H3 from binding to any other DNA in the nucleus. This hypothesis could be proven with a swap
of charges: making the PEST region basic and the H3 acidic to see the effect of both these
properties by DNA binding experiments.
With our proposed model for PU.1 regulation and dimeric complex formation along with
the new structure of PU.1 solved in chapter 4, 7K1T. We could utilize docking to analyze the
interface of PU.1 bound dimer. 7K1T (deleting the DNA) would dock into the 7K1T complex
using a docking tool such as RosettaCommons (Version 3.12) to yield the protein-protein
interface. Additional non-computational experiments could be a cysteine mapping of the ETS
domain. Strategic cysteine (similar to the DKCDK) placement would give insight into the region
of the protein that is involved in the 2:1 complex. DNA binding experiments would demonstrate
the importance of those regions as it will have a poor binding affinity sue to its symmetry. While
the cysteine in the areas that PU.1 forms an unbound dimer (symmetric dimer) will have yield a
unique CD spectra similar to the once we observed in Chapter 3.
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Recently it was proposed that transcriptional control may be driven by liquid-liquid phase
separation (261) Liquid-liquid phase separation (LLP) is a process when a homogenous mixture
separates into two liquids apart (262) a concentrated macromolecule phase (coacervation) (263)
and a dilute macromolecule phase. LLP have been associated with various biological roles such
as elastin whose polymeric assembly depends on phase separation (264) RNA metabolism (265)
and chromatin rearrangement (266). These LLPs formations are deemed to occur as weak
interactions mediated by the protein’s intrinsically disordered regions (IDRs) (267). Eukaryotic
transcription factors, as described in the introduction section, are abundant in IDRs (45,268) with
an abundance of both positive charges (clustered in the DNA binding domain) and negative
charges dispersed throughout the IDRs (269,270). The architecture of these TF allows them to be
highly dynamic adapting various conformations, form fuzzy complexes (155,271) and facilitate
phase

separation

of

condensates

(272-275)

Due

to

their

weak

interactions

associations/dissociations serves as a regulatory mechanism in gene expression including
chromatin structure organization (276).
In Chapter 3 we demonstrated that transcription factor PU.1 forms a weak dimeric
interaction in the absence of DNA serving as a reservoir of active PU.1 (155). Additionally, PU.1
has pioneering properties as it engages with closed chromatin and consequently recruiting the
transcription machinery for intuition (29,32,33). Considering the data and the essential role of PU.1
in biology it is an easy assumption to think it undergoes LLPS as a mechanism for selfpreservation. Experiments to prove such a transition occurs would have to be carried out with both
constructs ΔN117 and ΔN165 as well as a well-known protein already demonstrating LLPS such
as lysozyme at high concentration. Lysozyme and ΔN165 would serve as negative controls as they
don’t not possess IDRs present in ΔN117 which facilitate LLPS formation. The experiments would
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require a high concentration of protein to see the droplet formation both with and without DNA.
Experiments to scan optimal conditions (buffer and protein) would give clear transitional state of
LLPS formation. From Chapter 3 we also know that the ETS domain alone can form dimers under
low salt conditions, which could be explored further by trying to form LLPS droplets at different
salt ranges. The experiments would be pretty straight forward as the droplets are big enough to see
in a bright-field microscopy.
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